https://curecurrent.com/trials/a-trial-investigating-the-exposure-of-nn5401-in-young-adults-and-elderly-subjects-with-type-1-diabetes-20001https://curecurrent.com/trials/effects-of-different-mode-of-exercise-training-on-type-2-diabetes-20002https://curecurrent.com/trials/effects-of-electromagnetic-therapy-versus-laser-therapy-on-peripheral-diabetic-neuropathy-20003https://curecurrent.com/trials/a-smartphone-application-to-improve-medication-adherence-among-people-with-type-2-diabetes-mellitus-in-singapore-20004https://curecurrent.com/trials/a-trial-investigating-the-total-exposure-of-nn5401-insulin-degludec-insulin-aspart-in-children-adolescents-and-adult-sub-20005https://curecurrent.com/trials/safety-tolerability-and-pk-of-imeglimin-in-japanese-volunteers-20006https://curecurrent.com/trials/a-trial-investigating-the-pharmacodynamic-properties-of-nn5401-in-subjects-with-type-1-diabetes-20007https://curecurrent.com/trials/investigation-of-the-response-relationship-of-nn5401-in-type-1-diabetics-20008https://curecurrent.com/trials/comparison-of-the-blood-sugar-lowering-effect-between-repaglinide-plus-metformin-and-repaglinide-alone-in-type-2-diabeti-20009https://curecurrent.com/trials/the-importance-of-glp-1-in-post-rygb-improvement-in-glycaemic-control-type-2-diabetic-subjects-20010https://curecurrent.com/trials/two-bag-system-for-hydration-in-diabetes-20011https://curecurrent.com/trials/itopride-hydrochloride-in-diabetes-effects-on-gastric-emptying-and-glycemia-20012https://curecurrent.com/trials/efficacy-and-safety-of-liraglutide-versus-lixisenatide-as-add-on-to-metformin-in-subjects-with-type-2-diabetes-20013https://curecurrent.com/trials/liraglutide-as-additional-treatment-in-patients-with-type-1-diabetes-mellitus-20014https://curecurrent.com/trials/comparison-of-nn5401-versus-biphasic-insulin-aspart-30-on-a-twice-daily-regimen-in-subjects-with-type-2-diabetes-mellitu-20015https://curecurrent.com/trials/comparison-of-nn1250-with-insulin-glargine-in-type-2-diabetes-20016https://curecurrent.com/trials/a-randomized-controlled-trial-of-exercise-training-among-men-with-type-2-diabetes-20017https://curecurrent.com/trials/comparison-of-novofine-needles-4-mm-vs-6-mm-20018https://curecurrent.com/trials/a-care-model-for-hip-fractured-elderly-persons-with-diabetes-mellitus-20019https://curecurrent.com/trials/observational-study-of-novopen-echo-on-safety-and-treatment-satisfaction-in-children-and-adolescents-with-type-1-diabete-20020https://curecurrent.com/trials/the-effect-of-liraglutide-adjunct-to-insulin-on-glucagon-response-to-hypoglycaemia-in-subjects-with-type-1-diabetes-20021https://curecurrent.com/trials/effect-of-oral-contraceptives-after-administration-of-semaglutide-in-subjects-with-type-2-diabetes-20022https://curecurrent.com/trials/safety-and-tolerability-of-nn9068-in-healthy-male-volunteers-20023https://curecurrent.com/trials/a-phase-iii-study-of-bms-512148-dapagliflozin-in-asian-patients-with-type-2-diabetes-who-are-not-well-controlled-with-di-20024https://curecurrent.com/trials/integrated-impact-assessment-a-telemedicine-program-in-the-care-of-patients-with-diabetes-mellitus-type-1-intensive-trea-20025https://curecurrent.com/trials/the-alberta-diet-effectiveness-study-20026https://curecurrent.com/trials/lifestyle-intervention-and-prevention-of-gestational-diabetes-mellitus-20027https://curecurrent.com/trials/the-application-of-digital-infrared-thermal-imaging-in-peripheral-artery-disease-of-the-lower-extremities-20028https://curecurrent.com/trials/magnetic-resonance-diagnostics-of-diabetic-peripheral-neuropathy-20029https://curecurrent.com/trials/observational-study-on-safety-of-self-titration-of-once-daily-levemir-20030https://curecurrent.com/trials/laparoscopic-roux-en-y-gastric-bypass-versus-laparoscopic-biliopancreatic-diversion-bpd-duodenal-switch-for-superobesity-20031https://curecurrent.com/trials/surgical-intervention-for-morbidly-obese-adolescents-20032https://curecurrent.com/trials/glp-1-basal-insulin-combination-therapy-20033https://curecurrent.com/trials/insulin-sensitivity-irisin-and-adipokines-as-outcome-parameters-in-patients-undergoing-cardiac-surgery-20034https://curecurrent.com/trials/efficacy-and-safety-of-levemir-used-as-basal-insulin-20035https://curecurrent.com/trials/observational-study-describing-conditions-for-administering-slow-acting-insulin-analogue-with-oral-antidiabetic-agents-i-20036https://curecurrent.com/trials/an-observational-study-in-patients-using-novomix-30-or-levemir-for-treatment-of-type-1-or-type-2-diabetes-mellitus-20037https://curecurrent.com/trials/observational-study-of-the-predictability-of-levemir-in-terms-of-metabolic-control-change-of-body-weight-and-hypos-20038https://curecurrent.com/trials/telecare-in-type-1-diabetes-t1d-patients-treated-by-insulin-pump-20039https://curecurrent.com/trials/pharmacokinetics-of-insulin-detemir-in-healthy-volunteers-from-taiwan-20040https://curecurrent.com/trials/observational-study-to-observe-the-safety-of-levemir-treatment-in-children-and-adolescents-with-type-1-diabetes-20041https://curecurrent.com/trials/evaluation-of-absolve-in-diabetic-foot-ulcers-20042https://curecurrent.com/trials/observational-study-of-type-2-diabetes-patients-failing-on-oral-anti-diabetic-agents-initiated-on-levemir-or-insulatard-20043https://curecurrent.com/trials/the-effect-of-single-doses-of-the-motilin-receptor-agonist-gsk962040-in-type-i-diabetic-patients-with-gastroparesis-20044https://curecurrent.com/trials/prestudy-lifestyle-and-cardiovascular-disease-20045https://curecurrent.com/trials/antidiabetic-effects-of-adding-a-dpp-4-inhibitor-to-pre-existing-treatment-with-an-incretin-mimetic-in-patients-with-t2d-20046https://curecurrent.com/trials/effect-of-lixisenatide-on-postprandial-lipid-profile-in-obese-type-2-diabetic-patients-20047https://curecurrent.com/trials/a-12-week-multicentric-study-to-evaluate-the-safety-and-efficacy-of-bisoprolol-in-filipino-hypertensive-subjects-with-di-20048https://curecurrent.com/trials/within-subject-variability-of-insulin-detemir-in-children-and-adolescents-with-type-1-diabetes-20049https://curecurrent.com/trials/pharmacodynamics-and-pharmacokinetics-of-insulin-detemir-in-subjects-with-type-2-diabetes-20050https://curecurrent.com/trials/comparison-of-insulin-detemir-and-nph-with-respect-to-lowering-the-blood-sugar-and-symptoms-experienced-by-type-1-diabet-20051https://curecurrent.com/trials/frequency-of-hypoglycaemic-episodes-during-treatment-with-insulin-detemir-in-well-controlled-subjects-with-type-1-diabet-20052https://curecurrent.com/trials/safety-and-efficacy-of-insulin-detemir-in-combination-with-oad-in-type-2-diabetes-20053https://curecurrent.com/trials/suspending-basal-insulin-levels-for-exercise-in-adults-with-type-1-diabetes-20054https://curecurrent.com/trials/pharmacokinetics-of-insulin-detemir-in-subjects-with-type-1-diabetes-20055https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-insulin-detemir-and-nph-insulin-in-children-and-adolescents-with-type-1-diabetes-20056https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-insulin-detemir-and-insulin-glargine-in-patients-with-type-1-diabetes-20057https://curecurrent.com/trials/efficacy-and-the-safety-of-insulin-detemir-in-subjects-with-insulin-requiring-diabetes-20058https://curecurrent.com/trials/comparison-of-insulin-detemir-plus-insulin-aspart-with-insulin-nph-plus-human-soluble-insulin-in-subjects-with-type-1-di-20059https://curecurrent.com/trials/safety-and-efficacy-of-insulin-detemir-in-combination-with-oads-in-type-2-diabetes-20060https://curecurrent.com/trials/efficacy-and-safety-of-insulin-detemir-in-type-2-diabetes-inadequately-controlled-on-oha-therapy-alone-20061https://curecurrent.com/trials/comparison-of-insulin-detemir-with-nph-insulin-in-type-1-diabetes-20062https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-subjects-with-type-2-diabetes-20063https://curecurrent.com/trials/supplementation-of-vitamin-d-in-patients-with-type-2-diabetes-and-hypertension-20064https://curecurrent.com/trials/effect-of-liraglutide-on-absorption-of-paracetamol-in-subjects-with-type-2-diabetes-20065https://curecurrent.com/trials/metabolism-and-excretion-of-liraglutide-in-healthy-male-volunteers-20066https://curecurrent.com/trials/to-investigate-the-blood-concentration-of-liraglutide-as-well-as-the-effects-on-glucose-and-insulin-after-21-days-of-dai-20067https://curecurrent.com/trials/observational-study-on-effectiveness-and-safety-of-liraglutide-in-subjects-with-type-2-diabetes-20068https://curecurrent.com/trials/efficacy-of-administration-of-ace-inhibition-on-autonomic-and-peripheral-neuropathy-in-patients-with-diabetes-mellitus-20069https://curecurrent.com/trials/early-biomarkers-of-neurodevelopment-in-offspring-of-diabetic-mothers-20070https://curecurrent.com/trials/a-trial-to-assess-the-effect-of-liraglutide-on-blood-triglyceride-fat-levels-after-a-meal-in-type-2-diabetics-20071https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-diabetes-management-based-on-ubiquitous-healthcare-system-20072https://curecurrent.com/trials/comparison-of-liraglutide-injected-at-three-different-injection-sites-in-healthy-volunteers-20073https://curecurrent.com/trials/lifestyle-changes-in-patients-with-type-2-diabetes-mellitus-and-hypertension-20074https://curecurrent.com/trials/safety-and-tolerability-of-liraglutide-in-healthy-japanese-volunteers-20075https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-subjects-with-type-2-diabetes-20076https://curecurrent.com/trials/effect-of-liraglutide-on-gastrointestinal-absorption-of-several-drugs-and-potential-influence-of-liraglutide-on-intragas-20077https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-subjects-with-type-2-diabetes-20078https://curecurrent.com/trials/effect-of-liraglutide-as-add-on-to-metformin-compared-to-either-liraglutide-or-metformin-alone-or-to-a-combination-of-me-20079https://curecurrent.com/trials/effect-of-liraglutide-on-blood-glucose-control-in-japanese-subjects-with-type-2-diabetes-20080https://curecurrent.com/trials/safety-and-tolerability-of-liraglutide-in-healthy-japanese-male-volunteers-20081https://curecurrent.com/trials/remission-rate-of-newly-diagnosed-type-2-diabetes-outpatients-treated-with-short-term-intensive-insulin-therapy-20082https://curecurrent.com/trials/effect-of-liraglutide-compared-to-glimepiride-on-appetite-in-subjects-with-type-2-diabetes-20083https://curecurrent.com/trials/safety-and-tolerability-of-liraglutide-in-japanese-subjects-with-type-2-diabetes-20084https://curecurrent.com/trials/safety-and-tolerability-of-liraglutide-in-subjects-with-impaired-kidney-function-and-in-subjects-with-normal-kidney-func-20085https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-liraglutide-in-healthy-japanese-volunteers-20086https://curecurrent.com/trials/factors-in-accuracy-studies-influencing-measured-cgm-performance-20087https://curecurrent.com/trials/evaluate-the-pharmacokinetics-of-simvastatin-when-coadministered-with-pex168-in-healthy-adult-subjects-20088https://curecurrent.com/trials/a-2-year-trial-of-patients-with-type-2-diabetes-focusing-on-cardiovascular-diagnostics-and-metabolic-control-20089https://curecurrent.com/trials/efficacy-and-safety-study-of-pex168-in-combination-therapy-diabetes-mellitus-type-2-patients-with-metformin-20090https://curecurrent.com/trials/effect-of-liraglutide-on-pulsatile-insulin-secretion-in-subjects-with-type-2-diabetes-20091https://curecurrent.com/trials/effect-of-liraglutide-on-glucose-profiles-and-gastric-emptying-in-subjects-with-type-2-diabetes-20092https://curecurrent.com/trials/efficacy-and-safety-study-of-pex168-in-monotherapy-diabetes-mellitus-type-2-patients-20093https://curecurrent.com/trials/effect-of-exercise-on-the-absorption-of-inhaled-human-insulin-in-subjects-with-type-1-diabetes-20094https://curecurrent.com/trials/comparison-of-the-effect-of-liraglutide-in-young-versus-elderly-healthy-volunteers-20095https://curecurrent.com/trials/comparison-of-liraglutide-and-glimepiride-on-blood-sugar-control-in-subjects-with-type-2-diabetes-20096https://curecurrent.com/trials/metabolic-effects-of-stevia-in-type-2-diabetic-patients-20097https://curecurrent.com/trials/metformin-extended-release-versus-metformin-immediate-release-in-subjects-with-type-2-diabetes-20098https://curecurrent.com/trials/influence-on-the-effect-of-an-oral-contraceptive-drug-after-administration-of-liraglutide-in-postmenopausal-women-20099https://curecurrent.com/trials/safety-and-tolerability-of-liraglutide-in-healthy-male-volunteers-20100https://curecurrent.com/trials/evaluate-the-pharmacokinetics-of-digoxin-when-coadministered-with-pex168-in-healthy-adult-subjects-20101https://curecurrent.com/trials/evaluate-the-pharmacokinetics-of-warfarin-when-coadministered-with-pex168-in-healthy-adult-subjects-20102https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-in-subjects-with-type-1-diabetes-20103https://curecurrent.com/trials/rosiglitazone-and-plaque-study-for-type-2-diabetes-mellitus-20104https://curecurrent.com/trials/a-trial-to-investigate-the-impact-of-nocturnal-hypoglycaemia-on-sleep-in-subjects-with-type-2-diabetes-20105https://curecurrent.com/trials/a-trial-evaluating-the-blood-glucose-lowering-effect-of-nn1250-in-subjects-with-type-2-diabetes-20106https://curecurrent.com/trials/a-trial-investigating-the-concentration-in-the-blood-of-nn1250-in-children-adolescents-and-adults-with-type-1-diabetes-20107https://curecurrent.com/trials/a-trial-investigating-the-effect-of-nn1250-in-young-and-elderly-subjects-with-type-1-diabetes-20108https://curecurrent.com/trials/clinical-study-of-tang-wang-prescription-intervene-diabetic-non-proliferative-retinopathy-20109https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-mode-of-action-in-the-body-and-safety-profiles-of-nn1250-insulin-degludec-in-s-20110https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-children-with-type-1-diab-20111https://curecurrent.com/trials/a-trial-investigating-the-effect-of-nn1250-in-japanese-subjects-with-type-1-diabetes-20112https://curecurrent.com/trials/comparison-of-hypoglycaemic-response-between-nn1250-and-insulin-glargine-in-type-1-diabetics-20113https://curecurrent.com/trials/a-trial-investigating-the-nn1250-concentration-time-curve-in-subjects-with-various-degrees-of-renal-impairment-and-in-su-20114https://curecurrent.com/trials/a-trial-comparing-the-effect-of-nn1250-after-different-routes-of-injection-in-healthy-subjects-20115https://curecurrent.com/trials/a-study-to-investigate-how-common-pancreatic-exocrine-insufficiency-pei-is-in-patients-with-type-2-diabetes-and-also-to-20116https://curecurrent.com/trials/comparison-of-two-pen-systems-in-patients-with-diabetes-treated-with-insulin-20117https://curecurrent.com/trials/to-estimate-the-percentage-of-children-and-adolescents-in-tunisia-with-acceptably-controlled-diabetes-mellitus-type-1-20118https://curecurrent.com/trials/evaluating-the-use-of-two-different-needles-in-subjects-with-diabetes-20119https://curecurrent.com/trials/changing-diabetes-world-tour-20120https://curecurrent.com/trials/the-effect-of-plant-sterols-on-the-blood-lipid-profile-of-subjects-with-and-at-high-risk-of-type-2-diabetes-mellitus-20121https://curecurrent.com/trials/observational-study-on-the-effect-of-novomix-30-levemir-or-novorapid-alone-or-combined-in-type-2-diabetics-previously-tr-20122https://curecurrent.com/trials/french-observational-survey-to-assess-hypoglycaemia-in-insulin-treated-diabetic-patients-20123https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-indi-20124https://curecurrent.com/trials/safety-and-efficacy-study-of-autologous-stem-cell-transplantation-for-early-onset-type-i-diabetes-mellitus-20125https://curecurrent.com/trials/a-trial-investigating-the-pharmacodynamic-response-of-faster-acting-insulin-aspart-in-subjects-with-type-1-diabetes-20126https://curecurrent.com/trials/study-of-the-potential-of-a-macronutrient-balanced-normocaloric-diet-to-treat-lifestyle-diseases-20127https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-and-pharmacodynamic-properties-of-fiasp-in-subjects-with-type-1-diabetes-20128https://curecurrent.com/trials/assessment-of-insulin-sensitivity-and-cell-function-by-clamps-studies-20129https://curecurrent.com/trials/a-randomised-trial-investigating-the-pharmacokinetic-and-pharmacodynamic-properties-of-faster-acting-insulin-aspart-in-s-20130https://curecurrent.com/trials/heidelberg-study-on-diabetes-and-complications-20131https://curecurrent.com/trials/the-glycaemic-effect-of-isomaltulose-consumption-in-healthy-participants-20132https://curecurrent.com/trials/effect-of-different-insulin-administrations-all-in-combination-with-metformin-on-glycaemic-control-in-subjects-with-type-20133https://curecurrent.com/trials/dose-ranging-study-of-albiglutide-in-japanese-subjects-20134https://curecurrent.com/trials/telemetric-glucose-data-acquisition-during-initiation-of-insulin-pump-therapy-20135https://curecurrent.com/trials/a-study-of-the-effect-of-glucagon-like-peptide-1-glp-1-receptor-agonist-in-combination-with-metformin-therapy-on-diabete-20136https://curecurrent.com/trials/development-and-assessment-of-feasibility-of-non-invasive-multiple-sensor-hypo-sense-as-a-tool-for-detection-of-hypoglyc-20137https://curecurrent.com/trials/observational-study-evaluating-the-safety-of-novomix-in-type-2-diabetes-patients-previously-treated-with-a-human-premix-20138https://curecurrent.com/trials/md-logic-pump-advisor-adults-study-20139https://curecurrent.com/trials/overnight-md-logic-20140https://curecurrent.com/trials/long-term-treatment-effect-of-the-safety-tolerability-and-efficacy-of-aat-in-type-1-diabetes-20141https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-in-subjects-with-type-2-diabetes-20142https://curecurrent.com/trials/md-logic-pump-advisor-pediatric-study-20143https://curecurrent.com/trials/coronary-artery-plaque-burden-and-morphology-in-type-2-diabetes-mellitus-20144https://curecurrent.com/trials/cgm-treatment-in-patients-with-type-1-diabetes-treated-with-insulin-injections-20145https://curecurrent.com/trials/association-between-glycaemic-control-and-morbi-mortality-after-5-years-of-follow-up-in-type-2-diabetic-patients-20146https://curecurrent.com/trials/peroxisome-proliferator-activated-receptor-gamma-ppar-gamma-agonist-in-diabetic-end-stage-renal-disease-patients-20147https://curecurrent.com/trials/metabolic-profiling-of-type-1-diabetes-mellitus-in-children-and-adolescents-20148https://curecurrent.com/trials/observational-study-of-patients-using-novomix-30-or-levemir-for-treatment-of-type-1-or-type-2-diabetes-20149https://curecurrent.com/trials/an-open-study-to-evaluate-whether-pack-size-affects-compliance-of-metformin-treatment-in-subjects-with-type-ii-diabetes-20150https://curecurrent.com/trials/glycaemic-control-and-quality-of-care-in-type-2-diabetes-on-novomix-30-previously-treated-with-mixtard-insulins-20151https://curecurrent.com/trials/an-observational-study-of-type-2-diabetes-in-patients-starting-on-novomix-30-treatment-20152https://curecurrent.com/trials/physiological-concept-of-insulin-therapy-in-subjects-with-type-2-diabetes-20153https://curecurrent.com/trials/frequency-of-episodes-of-hypoglycaemia-during-treatment-with-biphasic-insulin-aspart-30-in-type-2-diabetes-20154https://curecurrent.com/trials/observational-study-of-safety-of-novomix-30-treatment-for-type-2-diabetes-20155https://curecurrent.com/trials/mirabegron-and-brown-adipose-tissue-20156https://curecurrent.com/trials/basal-bolus-of-insulin-aspart-including-insulin-nph-and-biphasic-insulin-aspart-in-type-2-diabetes-20157https://curecurrent.com/trials/effectiveness-and-safety-of-biphasic-insulin-aspart-70-30-in-subjects-with-type-2-diabetes-20158https://curecurrent.com/trials/comparison-of-pharmacodynamics-and-pharmacokinetics-of-biphasic-insulin-aspart-30-and-insulin-glargine-and-insulin-gluli-20159https://curecurrent.com/trials/bioequivalence-of-two-formulations-of-biphasic-insulin-aspart-70-in-healthy-subjects-20160https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-with-metformin-in-type-2-diabetes-20161https://curecurrent.com/trials/comparison-of-the-pharmacodynamics-and-pharmacokinetics-of-biphasic-insulin-aspart-30-50-70-and-insulin-aspart-in-subjec-20162https://curecurrent.com/trials/comparison-of-pharmacodynamics-and-pharmacokinetics-of-biphasic-insulin-aspart-50-to-biphasic-insulin-aspart-70-in-type-20163https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-flexpen-in-insulin-naive-subjects-with-type-2-diabetes-20164https://curecurrent.com/trials/efficacy-and-safety-of-three-times-a-day-biasp-70-compared-to-two-times-a-day-biasp-30-in-subjects-with-type-2-diabetes-20165https://curecurrent.com/trials/observational-study-of-biphasic-insulin-aspart-30-alone-or-in-combination-with-oral-hypoglycaemic-agents-in-subjects-wit-20166https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-biphasic-insulin-aspart-30-and-biphasic-human-insulin-30-in-type-2-diabetes-20167https://curecurrent.com/trials/observational-safety-study-in-subjects-with-type-2-diabetes-mellitus-starting-or-switching-to-biphasic-insulin-aspart-30-20168https://curecurrent.com/trials/effect-of-biphasic-insulin-aspart-30-on-blood-glucose-control-in-subjects-with-type-2-diabetes-20169https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-in-combination-with-metformin-in-type-2-diabetes-20170https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-70-30-50-50-and-30-70-in-subjects-with-type-2-diabetes-20171https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-biphasic-insulin-aspart-30-and-50-in-subjects-with-type-2-diabetes-20172https://curecurrent.com/trials/comparison-of-single-dose-and-steady-state-pharmacodynamics-of-biphasic-insulin-aspart-30-and-70-in-subjects-with-type-1-20173https://curecurrent.com/trials/the-multi-centric-clinical-study-of-chinese-medicine-intervention-on-diabetes-distal-symmetric-polyneuropathy-20174https://curecurrent.com/trials/pharmacokinetics-of-biphasic-insulin-aspart-30-and-70-in-subjects-with-type-1-diabetes-20175https://curecurrent.com/trials/pharmacokinetics-of-biphasic-insulin-aspart-50-and-70-in-japanese-healthy-volunteers-20176https://curecurrent.com/trials/glycaemic-control-of-biphasic-insulin-aspart-70-and-30-in-subjects-with-type-2-diabetes-20177https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-biphasic-insulin-aspart-30-in-healthy-volunteers-20178https://curecurrent.com/trials/the-multi-center-clinical-study-of-tang-shen-prescription-on-type-2-diabetic-kidney-disease-in-early-stage-20179https://curecurrent.com/trials/comparison-of-biphasic-insulin-aspart-30-50-and-70-and-insulin-aspart-in-healthy-subjects-20180https://curecurrent.com/trials/safety-and-efficacy-of-insulin-aspart-in-subjects-with-type-1-diabetes-20181https://curecurrent.com/trials/micronutrients-in-pregnancy-as-a-risk-factor-for-diabetes-and-effects-on-mother-and-baby-20182https://curecurrent.com/trials/comparing-semaglutide-administered-subcutaneously-once-daily-to-semaglutide-administered-subcutaneously-once-weekly-20183https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-in-type-1-or-type-2-diabetes-20184https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-safety-of-biphasic-insulin-aspart-30-in-type-2-diabetes-20185https://curecurrent.com/trials/help-apheresis-in-diabetic-ischemic-foot-treatment-h-a-d-i-f-20186https://curecurrent.com/trials/comparison-of-biphasic-human-insulin-30-with-biphasic-insulin-aspart-in-subjects-with-diabetes-20187https://curecurrent.com/trials/living-with-statins-the-impact-of-cholesterol-lowering-drugs-on-health-lifestyle-and-well-being-20188https://curecurrent.com/trials/treatment-of-chronic-diabetic-foot-ulcers-by-minimally-invasive-surgery-20189https://curecurrent.com/trials/melatonin-and-glucose-tolerance-among-individuals-with-a-variant-of-the-mtnr1b-gene-20190https://curecurrent.com/trials/an-observational-study-to-assess-safety-and-effectiveness-of-intravenous-novorapid-in-hospitalised-subjects-20191https://curecurrent.com/trials/comparison-of-two-biphasic-insulin-aspart-treatments-in-subjects-with-type-2-diabetes-20192https://curecurrent.com/trials/a-study-to-test-the-effectiveness-and-safety-of-mk0893-in-combination-with-other-drugs-used-to-treat-type-2-diabetes-089-20193https://curecurrent.com/trials/stratification-of-risk-of-diabetes-in-early-pregnancy-20194https://curecurrent.com/trials/add-on-pentoxifylline-to-losartan-versus-increasing-dose-of-losartan-on-nt-pro-bnp-in-type-2-diabetics-with-nephropathy-20195https://curecurrent.com/trials/lipo-prostaglandin-e1-improves-renal-hypoxia-evaluated-by-bold-mri-in-patients-with-diabetic-nephropathy-20196https://curecurrent.com/trials/a-study-of-the-gi-sleeve-for-the-treatment-of-type-2-diabetes-20197https://curecurrent.com/trials/glycemic-index-variation-during-low-carbohydrate-enteral-formula-with-and-without-fructose-in-critically-ill-patients-20198https://curecurrent.com/trials/intestinal-remodeling-and-reprogramming-of-glucose-metabolism-following-laparoscopic-roux-en-y-gastric-bypass-20199https://curecurrent.com/trials/exenatide-and-brown-adipose-tissue-20200https://curecurrent.com/trials/thyroid-function-and-diabetes-complications-20201https://curecurrent.com/trials/efficacy-and-safety-of-insulin-aspart-in-subjects-with-type-1-or-type-2-diabetes-20202https://curecurrent.com/trials/comparison-of-antibody-levels-in-children-and-adolescents-after-initiation-of-insulin-therapy-by-either-insulin-aspart-o-20203https://curecurrent.com/trials/human-insulin-nph-and-insulin-aspart-in-type-1-diabetes-20204https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-in-monot-20205https://curecurrent.com/trials/effect-of-acarbose-and-vildagliptin-on-visceral-fat-distribution-in-newly-diagnosed-type-2-diabetes-patients-20206https://curecurrent.com/trials/efficacy-and-safety-of-insulin-aspart-vs-human-insulin-during-pregnancy-by-women-with-type-1-diabetes-20207https://curecurrent.com/trials/the-study-of-cctm-and-common-diseases-20208https://curecurrent.com/trials/efficacy-and-safety-of-insulin-aspart-in-mdi-or-csii-in-children-below-7-years-of-age-with-type-1-diabetes-20209https://curecurrent.com/trials/heart-rate-variability-and-diabetic-kidney-disease-in-type-2-diabetes-mellitus-patients-20210https://curecurrent.com/trials/a-post-marketing-surveillance-pms-study-of-liraglutide-in-subjects-with-type-2-diabetes-mellitus-in-india-20211https://curecurrent.com/trials/making-ramadhan-fasting-a-safer-experience-with-technology-study-20212https://curecurrent.com/trials/a-trial-comparing-the-effect-of-exercise-on-blood-glucose-in-subjects-with-type-1-diabetes-who-are-treated-with-either-i-20213https://curecurrent.com/trials/strength-training-in-walking-tolerance-in-intermittent-claudication-patients-20214https://curecurrent.com/trials/autologous-transplantation-of-bm-ecs-with-platelet-rich-plasma-extract-for-the-treatment-of-critical-limb-ischemia-20215https://curecurrent.com/trials/tolvaptan-for-in-hospital-hyponatremia-20216https://curecurrent.com/trials/a-pilot-study-of-a-community-health-agent-led-diabetes-self-management-program-20217https://curecurrent.com/trials/observational-study-on-efficacy-safety-and-convenience-of-using-mixtard-30-novolet-alone-or-combined-with-oha-in-treatme-20218https://curecurrent.com/trials/comparison-of-everolimus-eluting-stent-vs-sirolimus-eluting-stent-in-patients-with-diabetes-mellitus-20219https://curecurrent.com/trials/observational-study-to-evaluate-safety-efficacy-and-convenience-of-using-novomix-30-flexpen-in-type-2-diabetes-20220https://curecurrent.com/trials/glycaemic-response-to-oral-nutrition-support-during-haemodialysis-20221https://curecurrent.com/trials/a-single-dose-cross-over-study-to-assess-direct-and-indirect-effects-of-dapagliflozin-on-pancreatic-alpha-and-beta-cells-20222https://curecurrent.com/trials/effects-of-dietary-flaxseed-on-symptoms-of-cardiovascular-disease-in-patients-with-peripheral-arterial-disease-20223https://curecurrent.com/trials/can-vitamin-d-supplementation-prevent-type-2-diabetes-20224https://curecurrent.com/trials/a-feasibility-study-looking-at-the-use-of-glibenclamide-and-metformin-versus-standard-care-in-gestational-diabetes-20225https://curecurrent.com/trials/an-observational-study-in-type-2-diabetic-patients-on-oral-antidiabetic-drugs-and-basal-insulin-in-near-east-countries-20226https://curecurrent.com/trials/evaluation-of-myocardial-perfusion-heterogeneity-imaging-in-diabetes-patients-evadiab-20227https://curecurrent.com/trials/effects-of-nutrition-meal-replacement-and-individualized-exercise-prescription-on-type-2-diabetes-20228https://curecurrent.com/trials/1-2-rosuvastatin-subgingivally-delivered-in-chronic-periodontitis-with-type-2-diabetes-mellitus-20229https://curecurrent.com/trials/the-comparison-of-quality-of-life-in-patients-with-pancreatogenic-diabetes-after-pancreatectomy-20230https://curecurrent.com/trials/influence-of-insulin-on-bp-change-during-adolescence-20231https://curecurrent.com/trials/effect-of-anthocyanins-on-metabolic-profiles-in-subjects-with-pre-diabetes-20232https://curecurrent.com/trials/comparison-of-mystar-dosecoach-to-routine-titration-in-adult-patients-with-type-2-diabetes-mellitus-using-toujeo-20233https://curecurrent.com/trials/co2-laser-treatment-in-patients-with-diabetic-infected-foot-ulcers-20234https://curecurrent.com/trials/diagnosis-of-gestational-diabetes-in-eldoret-kenya-20235https://curecurrent.com/trials/a-study-to-assess-the-effect-of-a-normal-vs-high-protein-diets-in-carbohydrates-metabolism-in-obese-subjects-with-diabet-20236https://curecurrent.com/trials/risk-factors-for-low-lymphocyte-count-in-patients-with-type-2-diabetes-20237https://curecurrent.com/trials/the-influence-of-conversation-map-on-the-health-behaviors-of-diabetes-patients-20238https://curecurrent.com/trials/relations-between-atherogenic-index-of-plasma-glucose-metabolism-20239https://curecurrent.com/trials/magnesium-treatment-of-inflammation-in-disorders-of-glucose-homeostasis-20240https://curecurrent.com/trials/evaluation-of-functional-insulin-therapy-in-type-1-diabetic-patients-20241https://curecurrent.com/trials/omega-3-fatty-acids-supplementation-and-atherothrombotic-biomarkers-in-type-2-diabetes-and-cardiovascular-disease-20242https://curecurrent.com/trials/impact-of-food-carbohydrate-and-insulin-dose-computing-by-on-smart-phone-on-glucose-control-in-patients-with-diabetes-20243https://curecurrent.com/trials/effectiveness-of-self-care-rests-on-knowledge-self-care-and-cardiometabolic-control-of-adult-men-with-diabetes-mellitus-20244https://curecurrent.com/trials/consumption-of-apple-juice-in-hemodialysis-patients-20245https://curecurrent.com/trials/safety-follow-up-on-children-and-adolescents-with-type-1-diabetes-treated-with-insulin-detemir-an-extension-to-trial-nn3-20246https://curecurrent.com/trials/effects-of-lixisenatide-compared-to-liraglutide-on-the-postprandial-plasma-glucose-in-patients-with-type-2-diabetes-20247https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-and-metformin-fixed-dose-combination-in-participants-with-type-2-diabetes-20248https://curecurrent.com/trials/observational-study-of-patients-using-levemir-or-insulatard-as-start-insulin-for-treatment-of-diabetes-20249https://curecurrent.com/trials/the-role-of-endogenous-lactate-in-brain-preservation-and-counterregulatory-defenses-against-hypoglycemia-20250https://curecurrent.com/trials/observational-study-in-type-2-diabetics-treated-by-an-intensive-insulin-treatment-of-levemir-20251https://curecurrent.com/trials/observational-study-in-type-2-diabetics-failing-on-oral-antidiabetic-therapy-and-starting-on-insulin-treatment-20252https://curecurrent.com/trials/observational-study-of-novopen-4-on-treatment-satisfaction-of-insulin-therapy-in-type-1-or-type-2-subjects-with-diabetes-20253https://curecurrent.com/trials/effects-of-omega-3-plus-low-dose-aspirin-as-adjunct-to-periodontal-debridement-for-chronic-periodontitis-in-diabetics-20254https://curecurrent.com/trials/observational-study-on-the-weight-effect-of-insulin-detemir-levemir-in-type-2-diabetics-20255https://curecurrent.com/trials/therapy-of-obesity-and-diabetes-mellitus-type-2-20256https://curecurrent.com/trials/ern-hrungs-interventions-fettleber-studie-interventional-study-on-nutritional-effects-on-nafld-20257https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-thai-20258https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-mala-20259https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-sing-20260https://curecurrent.com/trials/the-glucopred-investigation-ii-20261https://curecurrent.com/trials/a-trial-investigating-the-continuous-subcutaneous-insulin-infusion-of-a-liquid-formulation-of-biochaperone-insulin-lispr-20262https://curecurrent.com/trials/special-drug-use-surveillance-of-pioglitazone-metformin-hydrochloride-combination-tablets-survey-on-long-term-use-for-ty-20263https://curecurrent.com/trials/efficacy-study-with-500-mg-qd-of-tro19622-vs-placebo-in-patients-with-painful-peripheral-diabetic-neuropathy-20264https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-taiw-20265https://curecurrent.com/trials/diabeloop-wp6-2-crossover-evaluation-of-glycemic-control-20266https://curecurrent.com/trials/investigate-the-efficacy-and-safety-of-gsk1070806-in-obese-subjects-with-t2dm-20267https://curecurrent.com/trials/a-comparison-of-atorvastatin-and-glimepiride-fixed-dose-combination-and-atorvastatin-and-glimepiride-loose-combination-i-20268https://curecurrent.com/trials/vasopressin-epinephrine-and-steroids-for-cardiac-arrest-20269https://curecurrent.com/trials/a-phase-2-clinical-study-to-investigate-effects-of-darapladib-in-subjects-with-diabetic-macular-edema-20270https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-placebo-on-the-incretin-effect-in-patients-with-type-2-diabetes-treated-20271https://curecurrent.com/trials/efficacy-of-vildagliptin-as-an-add-on-therapy-to-metformin-compared-to-metformin-up-titration-in-chinese-patients-with-t-20272https://curecurrent.com/trials/evaluation-of-cyclosporine-microemulsion-and-tacrolimus-on-the-rate-of-new-onset-diabetes-mellitus-in-kidney-transplanta-20273https://curecurrent.com/trials/efficacy-of-add-on-therapy-with-vildagliptin-in-chinese-patients-with-type-2-diabetes-inadequately-controlled-with-prior-20274https://curecurrent.com/trials/endocrine-regulation-of-lipolysis-in-obesity-and-diabetes-20275https://curecurrent.com/trials/efficacy-and-safety-of-vildagliptin-compared-to-gliclazide-in-drug-naive-patients-with-type-2-diabetes-20276https://curecurrent.com/trials/effect-of-laf237-on-glucagon-secretion-in-patients-with-type-2-diabetes-and-in-healthy-subjects-20277https://curecurrent.com/trials/vildagliptin-glycemic-profiles-assessment-using-a-continuous-glucose-monitoring-device-20278https://curecurrent.com/trials/safety-and-efficacy-of-vildagliptin-versus-nph-insulin-add-on-to-glimepiride-in-type-2-diabetes-mellitus-patients-20279https://curecurrent.com/trials/physical-activity-and-functioning-in-home-dialysis-patients-20280https://curecurrent.com/trials/exploratory-study-to-investigate-the-effect-of-dapagliflozin-and-exenatide-combined-on-body-weight-20281https://curecurrent.com/trials/meta-analyses-of-pasta-as-part-of-low-glycemic-index-diets-and-adiposity-20282https://curecurrent.com/trials/the-effect-of-whole-almonds-on-biomarkers-of-cardiovascular-disease-in-chinese-patients-with-type-2-diabetes-20283https://curecurrent.com/trials/the-effects-of-trichosanthes-root-on-blood-sugar-in-patients-with-diabetes-mellitus-20284https://curecurrent.com/trials/insulin-effects-on-cardiac-function-in-patients-with-diabetes-mellitus-20285https://curecurrent.com/trials/impact-of-gut-hormones-and-inflammatory-adipokines-in-obese-patients-underwent-bariatric-surgery-20286https://curecurrent.com/trials/evaluation-of-a-flash-glucose-monitoring-system-in-ambulatory-patients-with-type-1-diabetes-20287https://curecurrent.com/trials/polymorphisms-in-the-vitamin-d-system-and-health-20288https://curecurrent.com/trials/ivig-for-demyelination-in-diabetes-mellitus-20289https://curecurrent.com/trials/pioglitazone-tablets-special-drug-use-surveillance-combined-use-of-biguanides-long-term-treatment-20290https://curecurrent.com/trials/closed-loop-control-of-overnight-glucose-levels-artificial-pancreas-in-type-1-diab-tes-adults-with-hypoglycemia-unawaren-20291https://curecurrent.com/trials/dried-fruit-and-postprandial-glycemia-trial-20292https://curecurrent.com/trials/impact-of-3-year-lifestyle-intervention-on-postprandial-glucose-metabolism-the-slim-study-20293https://curecurrent.com/trials/exenatide-once-weekly-cardiovascular-risk-and-type-2-diabetes-20294https://curecurrent.com/trials/a-trial-investigating-the-pharmacokinetic-and-pharmacodynamic-properties-of-fiasp-when-administered-as-a-bolus-in-a-cont-20295https://curecurrent.com/trials/effect-of-fasting-therapy-on-blood-glucose-control-and-islet-function-in-newly-diagnosed-type-2-diabetic-patients-20296https://curecurrent.com/trials/evaluation-of-safety-and-parameters-of-application-technique-20297https://curecurrent.com/trials/observational-study-to-evaluate-safety-and-efficacy-of-insulin-therapy-in-type-2-diabetes-mellitus-subjects-failing-on-o-20298https://curecurrent.com/trials/exenatide-and-weight-loss-for-diabetes-prevention-20299https://curecurrent.com/trials/pharmaceutical-care-service-in-diabetes-20300https://curecurrent.com/trials/effect-of-anti-diabetic-drugs-on-bone-metabolism-and-glycemic-variability-20301https://curecurrent.com/trials/the-epass-clinical-trial-for-the-treatment-of-obese-subjects-20302https://curecurrent.com/trials/safety-and-efficacy-of-vildagliptin-plus-metformin-spc-treatment-in-type-2-diabetes-mellitus-patients-20303https://curecurrent.com/trials/incretin-based-drugs-and-acute-pancreatitis-20304https://curecurrent.com/trials/a-study-of-taspoglutide-in-type-2-diabetic-patients-20305https://curecurrent.com/trials/a-study-of-aleglitazar-in-monotherapy-in-patients-with-type-2-diabetes-mellitus-who-are-drug-na-ve-to-anti-hyperglycemic-20306https://curecurrent.com/trials/wound-healing-after-tooth-extraction-in-individuals-with-type-1-diabetes-mellitus-20307https://curecurrent.com/trials/a-study-of-ro6811135-in-patients-with-type-2-diabetes-who-are-inadequately-controlled-with-metformin-20308https://curecurrent.com/trials/a-study-of-alegitazar-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-alerenal-study-20309https://curecurrent.com/trials/a-study-to-compare-taspoglutide-and-insulin-glargine-in-insulin-na-ve-patients-with-type-2-diabetes-mellitus-inadequatel-20310https://curecurrent.com/trials/a-study-of-the-effect-of-taspoglutide-on-gastric-emptying-in-patients-with-type-2-diabetes-20311https://curecurrent.com/trials/a-study-of-aleglitazar-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-who-are-inadequately-cont-20312https://curecurrent.com/trials/a-study-of-the-effect-of-aleglitazar-on-insulin-sensitivity-in-patients-with-type-2-diabetes-mellitus-who-are-inadequate-20313https://curecurrent.com/trials/japanese-primary-prevention-of-atherosclerosis-with-aspirin-for-diabetes-jpad-trial-20314https://curecurrent.com/trials/a-study-of-single-doses-of-ro4998452-in-patients-with-type-2-diabetes-20315https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-aleglitazar-on-cardiac-energetics-and-function-in-patients-with-type-2-diabetes-mellit-20316https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-r1511-in-patients-with-type-2-diabetes-mellitus-20317https://curecurrent.com/trials/a-study-of-aleglitazar-in-type-2-diabetes-patients-with-moderate-renal-impairment-20318https://curecurrent.com/trials/the-role-of-the-duodenum-in-the-pathogenesis-of-insulin-resistance-and-type-2-diabetes-mellitus-20319https://curecurrent.com/trials/a-comparison-between-two-oral-hypoglycemics-metformin-and-glybenclamide-for-the-treatment-of-gestational-diabetes-mellit-20320https://curecurrent.com/trials/role-of-interleukin-6-in-exercise-20321https://curecurrent.com/trials/efficacy-and-safety-study-of-autologous-hematopoietic-stem-cell-transplantation-to-treat-new-onset-type-1-diabetes-20322https://curecurrent.com/trials/chinese-adolescent-registry-for-diabetes-card-study-20323https://curecurrent.com/trials/observational-study-to-assess-the-quality-of-life-and-clinical-outcomes-in-subjects-using-novomix-30-for-the-treatment-o-20324https://curecurrent.com/trials/observational-study-to-evaluate-the-efficacy-and-safety-of-novomix-30-in-type-1-and-2-diabetes-20325https://curecurrent.com/trials/observational-study-on-safety-and-efficacy-of-biphasic-insulin-aspart-in-type-2-diabetes-patients-20326https://curecurrent.com/trials/efficacy-and-safety-of-evogliptin-add-on-to-metformin-in-patients-with-type2-diabetes-20327https://curecurrent.com/trials/a-randomized-trial-of-diabetes-prevention-through-lifestyle-change-in-india-20328https://curecurrent.com/trials/an-observational-study-to-compare-the-safety-and-effectiveness-of-novomix-30-and-levemir-for-the-treatment-of-diabetes-20329https://curecurrent.com/trials/observational-study-on-blood-glucose-control-in-patients-with-diabetes-using-modern-insulin-20330https://curecurrent.com/trials/observational-study-to-observe-the-safety-of-novomix-30-treatment-in-patients-with-type-2-diabetes-20331https://curecurrent.com/trials/safety-of-treatment-initiation-with-biphasic-insulin-aspart-30-in-hospitalised-patients-with-type-2-diabetes-20332https://curecurrent.com/trials/observational-study-of-novomix-50-for-treatment-of-type-2-diabetics-for-12-months-20333https://curecurrent.com/trials/observational-study-on-efficacy-and-safety-in-patients-using-novomix-30-for-the-treatment-of-diabetes-20334https://curecurrent.com/trials/effect-of-biphasic-insulin-compared-to-biphasic-insulin-combined-with-insulin-aspart-with-or-without-metformin-in-type-2-20335https://curecurrent.com/trials/observational-study-to-evaluate-the-effectiveness-and-safety-of-levemir-novomix-30-and-novorapid-in-insulin-na-ve-subjec-20336https://curecurrent.com/trials/observational-study-on-treatment-satisfaction-of-levemir-versus-protaphane-during-real-life-usage-in-germany-20337https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-levemir-in-patients-with-diabetes-20338https://curecurrent.com/trials/surveillance-study-of-novorapid-for-new-drug-re-examination-20339https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-levemir-in-diabetes-20340https://curecurrent.com/trials/observational-study-to-evaluate-safety-of-levemir-in-type-1-and-type-2-diabetes-20341https://curecurrent.com/trials/evaluation-of-levemir-for-the-treatment-of-type-1-and-2-diabetes-20342https://curecurrent.com/trials/observational-safety-study-in-subjects-using-levemir-insulin-detemir-for-the-treatment-of-type-2-diabetes-mellitus-20343https://curecurrent.com/trials/observational-study-of-glycaemic-control-in-patients-uncontrolled-on-oral-antidiabetic-agents-and-starting-with-1-once-d-20344https://curecurrent.com/trials/an-observational-study-of-efficacy-and-safety-of-modern-insulin-in-diabetes-patients-switched-from-anti-diabetic-treatme-20345https://curecurrent.com/trials/observational-study-to-investigate-the-efficacy-and-safety-of-human-insulin-or-insulin-analogue-treatments-in-type-2-dia-20346https://curecurrent.com/trials/observational-study-to-assess-the-efficacy-and-safety-of-novorapid-flexpen-20347https://curecurrent.com/trials/observational-study-of-patients-using-novorapid-or-soluble-human-insulin-for-treatment-of-type-2-diabetes-20348https://curecurrent.com/trials/pharmacokinetics-of-insulin-detemir-in-healthy-chinese-male-subjects-20349https://curecurrent.com/trials/a-study-of-brl49653c-for-the-treatment-of-type-2-diabetes-20350https://curecurrent.com/trials/an-observational-study-evaluating-efficacy-safety-and-convenience-of-novonorm-in-treatment-of-type-2-diabetes-in-routine-20351https://curecurrent.com/trials/observational-study-on-blood-glucose-control-in-patients-with-diabetes-using-modern-insulin-20352https://curecurrent.com/trials/epigenetic-mechanisms-and-severe-obesity-biological-tissue-collection-20353https://curecurrent.com/trials/effect-of-rebound-exercise-in-individuals-with-type-2-diabetes-20354https://curecurrent.com/trials/a-trial-investigating-the-possible-difference-in-development-of-type-2-diabetes-between-caucasian-and-japanese-subjects-20355https://curecurrent.com/trials/effectiveness-tolerability-of-novel-initial-triple-combination-therapy-vs-conventional-therapy-in-type-2-diabetes-20356https://curecurrent.com/trials/post-marketing-surveillance-study-of-byetta-exenatide-use-among-filipino-patients-20357https://curecurrent.com/trials/assessment-of-patient-satisfaction-program-gestational-diabetes-20358https://curecurrent.com/trials/new-body-mass-index-bmi-cut-offs-for-the-diagnosis-of-obesity-and-comorbidities-20359https://curecurrent.com/trials/effects-of-purple-vegetables-on-cardiovascular-disease-cvd-risk-factors-20360https://curecurrent.com/trials/risk-of-hypoglycemia-in-type-2-diabetes-20361https://curecurrent.com/trials/efficacy-of-500-g-roflumilast-once-daily-versus-placebo-over-12-weeks-in-patients-with-diabetes-mellitus-type-2-a-double-20362https://curecurrent.com/trials/rowing-away-from-diabetes-20363https://curecurrent.com/trials/single-oral-dose-of-beneflax-to-healthy-young-and-older-adults-20364https://curecurrent.com/trials/comparison-of-weight-loss-induced-by-bariatric-surgery-vs-conventional-treatment-20365https://curecurrent.com/trials/the-flamenco-fitness-league-against-menopause-costs-project-20366https://curecurrent.com/trials/human-intestinal-peptides-evaluation-and-research-20367https://curecurrent.com/trials/the-diabetes-aerobic-and-resistance-bands-exercise-dare-bands-trial-20368https://curecurrent.com/trials/the-effects-of-self-management-education-based-on-theory-of-planned-behavior-on-patients-with-type-2-diabetes-20369https://curecurrent.com/trials/effects-of-lentil-consumption-on-post-prandial-blood-glucose-and-insulin-20370https://curecurrent.com/trials/dissection-of-the-gastrointestinal-mediated-glucose-disposal-and-incretin-defect-in-patients-with-type-2-diabetes-20371https://curecurrent.com/trials/study-of-copeptin-as-a-diagnostic-marker-for-acute-pancreatitis-20372https://curecurrent.com/trials/long-term-effects-of-intensive-insulin-treatment-in-type-1-diabetes-20373https://curecurrent.com/trials/mesenchymal-stromal-cell-derivatives-in-the-treatment-of-chronic-diabetic-foot-ulcers-type-1-and-2-20374https://curecurrent.com/trials/assessing-the-effect-of-met-dr-on-plasma-glucose-and-pk-in-subjects-with-t2dm-20375https://curecurrent.com/trials/effect-of-non-surgical-periodontal-treatment-on-hba1c-in-type-2-diabetic-patients-20376https://curecurrent.com/trials/cochlear-vestibular-ganglion-cvg-in-newly-diagnosed-type-2-diabetes-patients-20377https://curecurrent.com/trials/periodontal-and-salivary-evaluation-of-type-1-diabetes-mellitus-patients-20378https://curecurrent.com/trials/gemigliptin-rosuvastatin-fix-dose-combination-phase-3-balance-20379https://curecurrent.com/trials/pioglitazone-glimepiride-sonias-combination-tablets-special-drug-use-surveillance-survey-in-patients-with-type-2-diabete-20380https://curecurrent.com/trials/bioequivalence-of-two-insulin-aspart-formulations-100-u-ml-versus-200-u-ml-20381https://curecurrent.com/trials/pharmacokinetic-drug-interaction-study-with-dapagliflozin-and-glimepiride-in-healthy-subjects-20382https://curecurrent.com/trials/a-study-to-evaluate-the-effect-and-benefit-of-diabetes-management-decision-support-software-for-blood-glucose-control-20383https://curecurrent.com/trials/comparison-of-insulin-glargine-against-insulin-aspart-infused-under-the-skin-in-patients-with-type-2-diabetes-20384https://curecurrent.com/trials/effect-of-aspirin-versus-cilostazol-for-inhibition-of-antiplatelet-aggregation-in-type-2-dm-patients-20385https://curecurrent.com/trials/pharmacodynamic-effects-of-lixisenatide-compared-to-liraglutide-in-patients-with-type-2-diabetes-not-adequately-controll-20386https://curecurrent.com/trials/safety-and-efficacy-of-mesenchymal-precursor-cells-in-diabetic-nephropathy-20387https://curecurrent.com/trials/observational-study-of-type-1-diabetics-switching-from-human-insulins-to-modern-insulin-analogues-20388https://curecurrent.com/trials/novolet-acceptance-study-within-the-hospital-practise-in-indonesia-20389https://curecurrent.com/trials/a-survey-to-evaluate-diabetes-management-control-chronic-complications-psychosocial-aspects-of-diabetic-subjects-in-bang-20390https://curecurrent.com/trials/efficacy-and-safety-of-lixisenatide-in-patients-with-type-2-diabetes-mellitus-insufficiently-controlled-by-metformin-20391https://curecurrent.com/trials/autonomic-cardiovascular-neuropathy-in-recently-diagnosed-dm2-patients-acndm2-20392https://curecurrent.com/trials/a-decade-of-sleeve-gastrectomy-analysis-of-short-and-long-term-outcome-of-562-patients-20393https://curecurrent.com/trials/effects-of-vasopressors-on-immune-response-20394https://curecurrent.com/trials/observational-registry-for-basal-insulin-treatment-study-orbit-20395https://curecurrent.com/trials/fear-of-hypoglycemia-and-glycemic-variability-20396https://curecurrent.com/trials/carotid-atherosclerosis-and-vascular-events-in-people-with-diabetes-20397https://curecurrent.com/trials/closing-the-loop-in-adults-with-type-1-diabetes-and-hba1c-7-5-under-free-living-conditions-20398https://curecurrent.com/trials/glp-1-receptor-agonist-lixisenatide-in-patients-with-type-2-diabetes-for-glycemic-control-and-safety-evaluation-on-top-o-20399https://curecurrent.com/trials/dpp-iv-inhibition-facilitates-healing-of-chronic-foot-ulcers-in-type-2-diabetes-20400https://curecurrent.com/trials/incretin-effect-on-the-immunological-phenotype-20401https://curecurrent.com/trials/effectiveness-of-carbohydrate-counting-method-with-mixed-meals-20402https://curecurrent.com/trials/chrono-nutrition-cn-intervention-program-in-gestational-diabetes-mellitus-20403https://curecurrent.com/trials/role-of-carnosine-as-an-adjuvant-therapy-for-diabetic-nephropathy-in-pediatrics-with-type-1-diabetes-20404https://curecurrent.com/trials/automated-diagnostic-test-for-diabetic-retinopathy-in-brazilian-mass-screening-20405https://curecurrent.com/trials/white-blood-cell-spect-ct-and-diabetic-foot-osteomyelitis-20406https://curecurrent.com/trials/impact-of-structured-physical-activity-education-delivery-in-patients-with-type-2-diabetes-mellitus-20407https://curecurrent.com/trials/effectiveness-and-safety-of-salba-on-weight-loss-in-overweight-individuals-with-type-2-diabetes-20408https://curecurrent.com/trials/effect-of-more-distal-enteral-bypass-after-pancreaticoduodenectomy-a-prospective-multicenter-randomized-clinical-trial-20409https://curecurrent.com/trials/effect-of-lixisenatide-on-postprandial-plasma-glucose-compared-to-sitagliptin-in-combination-with-insulin-glargine-20410https://curecurrent.com/trials/retrograde-ejaculation-and-sexual-dysfunction-in-men-with-diabetes-mellitus-20411https://curecurrent.com/trials/the-effect-of-non-surgical-periodontal-therapy-plus-doxycycline-on-hba1c-in-patients-with-type-2-diabetes-mellitus-20412https://curecurrent.com/trials/using-of-ice-cream-for-diagnosis-of-diabetes-mellitus-20413https://curecurrent.com/trials/the-long-term-effect-of-tianqi-capsule-interventions-to-prevent-diabetes-in-the-reduces-study-a-8-year-follow-up-study-20414https://curecurrent.com/trials/effect-of-ginseng-in-type-2-diabetes-20415https://curecurrent.com/trials/safety-and-efficacy-study-of-endobarrier-in-subjects-with-type-ii-diabetes-and-obesity-20416https://curecurrent.com/trials/study-about-effect-of-saxagliptin-on-circulating-endothelial-progenitor-cells-and-endothelial-function-in-newly-diagnose-20417https://curecurrent.com/trials/technology-that-permits-focal-dose-of-antibiotics-to-be-delivered-to-lower-limb-s-of-diabetic-patients-20418https://curecurrent.com/trials/medlineplus-health-prescriptions-developing-a-pragmatic-approach-for-clinic-use-20419https://curecurrent.com/trials/a-mobile-and-web-based-clinical-decision-support-and-monitoring-system-for-diabetes-mellitus-patients-in-primary-care-20420https://curecurrent.com/trials/measuring-and-predicting-glycemic-response-to-food-in-patients-with-type-1-diabetes-20421https://curecurrent.com/trials/allogeneic-islet-transplantation-for-the-treatment-of-type-1-diabetes-20422https://curecurrent.com/trials/freestyle-libre-pro-use-in-primary-secondary-care-20423https://curecurrent.com/trials/ecm-and-blood-components-for-wound-healing-20424https://curecurrent.com/trials/assessing-health-outcomes-in-low-income-diabetics-who-receive-monthly-boxes-of-healthy-food-at-clinic-20425https://curecurrent.com/trials/detection-of-subclinical-atrial-fibrillation-in-high-risk-patients-using-implantable-loop-recorder-20426https://curecurrent.com/trials/alogliptin-tablets-special-drug-use-surveillance-type-2-diabetes-mellitus-combination-therapy-with-thiazolidinediones-20427https://curecurrent.com/trials/characteristics-of-popliteal-sciatic-nerve-block-in-patients-with-and-without-diabetic-neuropathy-20428https://curecurrent.com/trials/effects-of-sglt-2-inhibition-on-hepatic-glucose-and-energy-metabolism-20429https://curecurrent.com/trials/lifestat-living-with-statins-a-cross-sectional-study-20430https://curecurrent.com/trials/time-course-of-the-antiproteinuric-and-blood-pressure-lowering-effects-after-initiation-of-renin-inhibition-with-aliskir-20431https://curecurrent.com/trials/the-tantalus-ii-for-the-treatment-of-type-2-diabetes-20432https://curecurrent.com/trials/tantalus-therapy-in-type-2-diabetic-patients-intolerant-or-inadequately-responsive-to-glp-1-receptor-agonist-therapy-20433https://curecurrent.com/trials/effect-of-nrd135s-e1-in-peripheral-neuropathic-pain-in-diabetic-patients-20434https://curecurrent.com/trials/a-monotherapy-study-to-evaluate-the-efficacy-and-safety-of-2-dose-levels-of-albiglutide-in-japanese-subjects-with-type-2-20435https://curecurrent.com/trials/prevalence-of-diabetic-retinopathy-and-impact-of-genetic-factors-in-the-development-of-diabetic-retinopathy-of-patients-20436https://curecurrent.com/trials/mechanisms-and-reversibility-of-heart-failure-associated-with-diabetes-20437https://curecurrent.com/trials/the-influence-of-plaquenil-hydroxychloroquine-hcq-on-insulin-secretion-20438https://curecurrent.com/trials/risk-of-acute-kidney-injury-among-patients-with-type-2-diabetes-exposed-to-oral-antidiabetic-treatments-20439https://curecurrent.com/trials/vitamin-d-and-hba1c-levels-in-diabetic-patients-with-ckd-20440https://curecurrent.com/trials/risk-of-acute-liver-failure-among-patients-with-type-2-diabetes-exposed-to-oral-antidiabetic-treatments-20441https://curecurrent.com/trials/risk-of-hospitalized-infections-among-patients-with-type-2-diabetes-exposed-to-oral-antidiabetic-treatment-20442https://curecurrent.com/trials/effects-of-acute-exercise-on-acetylcarnitine-concentration-in-endurance-trained-and-untrained-subjects-20443https://curecurrent.com/trials/paleolithic-diet-in-the-treatment-of-glucose-intolerance-20444https://curecurrent.com/trials/risk-of-cardiovascular-events-in-patients-with-type-2-diabetes-initiating-oral-antidiabetic-treatments-20445https://curecurrent.com/trials/risk-of-hospitalization-for-severe-hypersensitivity-including-severe-skin-reactions-in-patients-with-type-2-diabetes-exp-20446https://curecurrent.com/trials/whey-protein-effect-on-glycaemic-and-appetite-responses-in-t2d-20447https://curecurrent.com/trials/gestational-diabetes-mellitus-obesity-and-periodontal-disease-20448https://curecurrent.com/trials/accelerated-wound-healing-in-diabetic-ulcers-by-sitagliptin-20449https://curecurrent.com/trials/fluid-retention-in-rosiglitazone-treated-subjects-with-autonomic-neuropathy-20450https://curecurrent.com/trials/examining-the-effect-of-different-diuretics-on-fluid-retention-in-diabetics-treated-with-rosiglitazone-20451https://curecurrent.com/trials/impact-of-a-sexology-consultation-on-disease-control-of-type-2-male-diabetics-with-erectile-dysfunction-20452https://curecurrent.com/trials/tapestry-for-people-with-cardiovascular-and-metabolic-disease-a-pilot-study-20453https://curecurrent.com/trials/project-ev-minus-regulatory-clinical-evaluation-system-accuracy-user-performance-and-system-use-evaluation-20454https://curecurrent.com/trials/project-bloom-regulatory-clinical-evaluation-system-accuracy-user-performance-and-system-use-evaluation-20455https://curecurrent.com/trials/assessment-of-sms-and-smartphone-interventions-for-onetouch-reveal-experiences-20456https://curecurrent.com/trials/evaluation-of-the-effect-of-sitagliptin-on-gut-microbiota-in-patients-with-newly-diagnosed-type-2-diabetes-20457https://curecurrent.com/trials/an-open-label-extension-to-protocol-09-1-efficacy-and-safety-study-of-the-endobarrier-gastrointestinal-liner-system-20458https://curecurrent.com/trials/low-glycemic-index-diet-for-type-2-diabetics-20459https://curecurrent.com/trials/diabetic-mellitus-patients-glucose-range-awareness-after-experiencing-a-new-blood-glucose-meter-feature-20460https://curecurrent.com/trials/patients-and-care-providers-perspectives-and-experience-with-decision-aid-tool-for-self-monitoring-of-blood-glucose-20461https://curecurrent.com/trials/use-of-canagliflozin-in-conjunction-with-insulin-in-a-real-world-setting-20462https://curecurrent.com/trials/forreal-forxiga-prescription-event-monitoring-program-pemp-20463https://curecurrent.com/trials/atherothrombosis-markers-in-diabetics-20464https://curecurrent.com/trials/par-4-and-telomere-telomerase-system-in-type-2-diabetes-patients-who-received-glp-1-or-metformin-treatment-20465https://curecurrent.com/trials/investigating-the-effect-of-liraglutide-on-the-endogenous-glucose-production-during-in-tye-1-diabetes-subjects-20466https://curecurrent.com/trials/pilot-study-investigating-the-feasibility-of-determining-the-endogenous-glucose-production-during-a-hypoglycaemia-20467https://curecurrent.com/trials/aspirin-and-renal-disease-progression-in-patients-with-type-2-diabetes-20468https://curecurrent.com/trials/european-open-label-prospective-multinational-multicenter-study-in-adult-subjects-with-type-1-or-type-2-diabetes-previou-20469https://curecurrent.com/trials/msc-administration-for-the-management-of-type-1-diabetic-patients-20470https://curecurrent.com/trials/a-trial-of-telmisartan-prevention-of-cardiovascular-disease-20471https://curecurrent.com/trials/prevalence-of-peripheral-neuropathy-in-children-and-adolescents-with-type-i-diabetes-mellitus-a-prospective-study-20472https://curecurrent.com/trials/an-investigational-drug-co-administered-with-insulin-in-patients-with-type-2-diabetes-0478-065-20473https://curecurrent.com/trials/effect-of-renin-angiotensin-system-blockers-on-glomerular-filtration-rate-in-patients-with-hypertension-type-2-diabetes-20474https://curecurrent.com/trials/cell-function-in-type-1-diabetes-may-not-be-as-low-as-presumed-20475https://curecurrent.com/trials/the-aboriginal-youth-mentorship-program-20476https://curecurrent.com/trials/safety-evaluation-of-the-klox-biophotonic-system-in-diabetic-foot-ulcers-20477https://curecurrent.com/trials/study-on-improvement-of-blood-glucose-control-in-patients-with-diabetes-type-2-using-smbg-20478https://curecurrent.com/trials/exenatide-plus-pioglitazone-versus-insulin-in-poorly-controlled-t2dm-20479https://curecurrent.com/trials/exercise-intervention-to-prevent-gestational-diabetes-20480https://curecurrent.com/trials/biological-changes-in-the-adipose-tissue-among-pregnant-women-with-diabetes-20481https://curecurrent.com/trials/a-study-to-evaluate-safety-pharmacokinetics-and-pharmacodynamics-of-a-single-dose-of-sar438544-in-comparison-to-glucagon-20482https://curecurrent.com/trials/evaluation-of-pharmacokinetics-and-pharmacodynamic-properties-of-rapid-acting-insulin-analogs-20483https://curecurrent.com/trials/fto-rs9939609-and-ppary-rs1801282-polymorphisms-in-mexican-adolescents-20484https://curecurrent.com/trials/liraglutide-and-heart-failure-in-type-2-diabetes-20485https://curecurrent.com/trials/effect-of-rosiglitazone-on-carotid-intima-media-thickness-in-patients-with-insulin-resistance-syndrome-and-or-type-2-dia-20486https://curecurrent.com/trials/study-of-avandamet-with-or-without-insulin-in-type-ii-diabetes-mellitus-patients-avandamet-is-a-registered-trademark-of-20487https://curecurrent.com/trials/sulphonylurea-receptor-mutation-and-responsiveness-to-gliclazide-a-pilot-proof-of-concept-randomised-cross-over-study-20488https://curecurrent.com/trials/diazoxide-choline-controlled-release-tablet-dccr-for-very-high-triglycerides-20489https://curecurrent.com/trials/system-accuracy-evaluation-of-2-ce-marked-blood-glucose-monitoring-system-20490https://curecurrent.com/trials/continuous-correction-20491https://curecurrent.com/trials/correlation-of-albuminuria-with-arterial-stiffness-20492https://curecurrent.com/trials/gene-polymorphism-associated-with-macroangiopathy-in-type-2-diabetes-patients-20493https://curecurrent.com/trials/bioflow-iii-all-comers-orsiro-safety-and-performance-registry-20494https://curecurrent.com/trials/renal-and-peripheral-hemodynamic-function-in-patients-with-type-1-diabetes-mellitus-20495https://curecurrent.com/trials/qingdao-diabetes-prevention-project-20496https://curecurrent.com/trials/treatment-of-wolfram-syndrome-type-2-with-the-chelator-deferiprone-and-incretin-based-therapy-20497https://curecurrent.com/trials/an-investigational-drug-study-in-patients-with-type-2-diabetes-mellitus-0431-024-20498https://curecurrent.com/trials/glycemic-index-in-subjects-with-diabetes-mellitus-insulin-requesting-20499https://curecurrent.com/trials/effect-of-nutritional-counseling-based-on-diet-quality-on-metabolic-control-in-patients-with-type-2-diabetes-mellitus-20500https://curecurrent.com/trials/efficacy-and-safety-study-of-linagliptin-5-mg-administered-orally-once-daily-over-24-weeks-in-type-2-diabetic-patients-w-20501https://curecurrent.com/trials/efficacy-and-safety-study-of-linagliptin-5-mg-administered-orally-once-daily-over-24-weeks-in-drug-na-ve-or-previously-t-20502https://curecurrent.com/trials/probucol-combined-with-valsartan-in-reducing-proteinuria-in-diabetes-nephropathy-20503https://curecurrent.com/trials/meta-analysis-of-the-effect-of-a-low-glycemic-index-diet-and-glycemic-load-on-body-weight-20504https://curecurrent.com/trials/a-multiple-dose-investigational-drug-study-in-patients-with-type-2-diabetes-mk-0941-005-20505https://curecurrent.com/trials/iranian-traditional-mouth-rinse-punica-granatum-pleniflora-golnaar-in-treatment-of-gingivitis-in-diabetic-patients-20506https://curecurrent.com/trials/meta-analyses-of-impotrant-food-sources-of-sugars-and-incident-cardiometabolic-diseases-20507https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-pharmacodynamics-of-gk-activator-2-in-type-2-diabetes-patients-with-hepatic-impairment-20508https://curecurrent.com/trials/diabetes-prevention-in-clinical-practice-20509https://curecurrent.com/trials/carbohydrate-restriction-for-gestational-diabetes-mellitus-20510https://curecurrent.com/trials/brief-intervention-to-promote-smoking-cessation-in-dm-smokers-20511https://curecurrent.com/trials/effects-of-exenatide-on-glycemic-control-and-weight-in-continuous-subcutaneous-insulin-infusion-csii-type-2-treated-pati-20512https://curecurrent.com/trials/fm-srp-and-tooth-extraction-improve-type-2-diabetes-mellitus-in-periodontitis-20513https://curecurrent.com/trials/heath-related-quality-of-life-of-diabetic-transmetatarsal-amputees-and-below-knee-prosthetic-users-20514https://curecurrent.com/trials/the-diagnosis-of-chronic-pancreatitis-20515https://curecurrent.com/trials/the-role-of-umbilical-cord-thickness-in-prediction-of-fetal-macrosomia-in-patients-with-gestational-diabetes-mellitus-20516https://curecurrent.com/trials/late-night-snack-and-insulin-glargine-20517https://curecurrent.com/trials/a-trial-to-investigate-post-prandial-blood-glucose-control-with-fast-acting-human-insulin-hinsbet-compared-to-insulin-li-20518https://curecurrent.com/trials/longitudinal-cohort-study-comparing-2-surgical-techniques-in-patients-with-class-3-obesity-and-type-2-diabetes-20519https://curecurrent.com/trials/yjp-14-capsules-for-the-treatment-of-endothelial-dysfunction-in-patients-with-diabetes-mellitus-20520https://curecurrent.com/trials/vildagliptin-vs-glibenclamide-in-endothelial-function-in-type-2-diabetes-and-hypertension-20521https://curecurrent.com/trials/comparison-of-two-protocols-on-the-implementation-of-a-fasting-day-in-type-1-diabetes-20522https://curecurrent.com/trials/glucagon-efficiency-after-high-and-low-carbohydrate-diet-20523https://curecurrent.com/trials/sms-technology-for-the-promotion-of-diabetes-education-and-self-management-in-egypt-20524https://curecurrent.com/trials/the-diabetes-and-aquatic-training-study-dats-20525https://curecurrent.com/trials/glp-1-mediating-dpp-4-inhibition-in-type-2-diabetes-20526https://curecurrent.com/trials/effects-of-shifting-from-twice-daily-insulin-glargine-or-detemir-to-once-daily-insulin-degludec-in-type-1-diabetes-20527https://curecurrent.com/trials/safety-and-efficacy-of-zp-glucagon-to-injectable-glucagon-for-hypoglycemia-20528https://curecurrent.com/trials/candida-albicans-in-periodontal-and-endodontic-lesions-in-diabetic-and-normoglycemic-patients-20529https://curecurrent.com/trials/european-transplant-registry-of-senior-renal-transplant-recipients-on-advagraf-20530https://curecurrent.com/trials/exercise-glucose-kinetics-and-the-incretin-effect-20531https://curecurrent.com/trials/effectiveness-and-safety-of-adipose-derived-regenerative-cells-for-the-treatment-of-critical-lower-limb-ischemia-20532https://curecurrent.com/trials/abbott-sensor-based-glucose-monitoring-system-paediatric-study-20533https://curecurrent.com/trials/modulating-the-stress-response-in-diabetes-mellitus-type-2-patients-undergoing-colon-surgery-20534https://curecurrent.com/trials/the-hanap-study-incentivized-partnerships-to-reduce-diabetes-disparities-20535https://curecurrent.com/trials/carbohydrate-estimation-supported-by-the-gocarb-system-20536https://curecurrent.com/trials/evaluation-of-the-effects-of-teleconsultations-on-a-endocrinology-referral-list-20537https://curecurrent.com/trials/antiproteinuric-effects-of-liraglutide-treatment-20538https://curecurrent.com/trials/impact-of-physical-activity-on-blood-glucose-stability-and-energy-stores-in-individuals-with-type-1-diabetes-20539https://curecurrent.com/trials/pdt-and-periodontal-treatment-in-dmt2-patients-20540https://curecurrent.com/trials/effect-of-a-continuous-glucose-monitoring-on-maternal-and-neonatal-outcomes-in-gestational-diabetes-mellitus-20541https://curecurrent.com/trials/description-of-the-evolution-of-a-cohort-of-adolescents-with-type-1-diabetes-following-their-participation-in-therapeuti-20542https://curecurrent.com/trials/comparison-of-th1-cytokine-levels-between-type-1-and-type-2-diabetes-20543https://curecurrent.com/trials/pioglitazone-on-cardiac-function-and-large-arteries-piccola-study-20544https://curecurrent.com/trials/evaluate-the-drug-drugs-interaction-between-lobeglitazone-and-empagliflozin-20545https://curecurrent.com/trials/evaluation-of-a-diabetes-self-management-education-program-for-non-intensified-insulin-therapy-in-type-2-diabetes-20546https://curecurrent.com/trials/insulin-resistance-atherosclerosis-study-iras-20547https://curecurrent.com/trials/to-develop-a-high-quality-health-care-delivery-model-for-the-management-of-hypertension-and-diabetes-at-chcs-and-distric-20548https://curecurrent.com/trials/the-effect-of-continuous-glucose-monitoring-on-glycemic-control-in-insulin-requiring-gestational-diabetes-mellitus-20549https://curecurrent.com/trials/effect-of-green-tea-epigallocatechin-gallate-on-albuminuria-in-patients-with-diabetic-nephropathy-20550https://curecurrent.com/trials/simvastatin-and-fenofibrate-vs-simvastatin-alone-in-patients-with-type-2-diabetes-mellitus-and-acute-coronary-syndrome-20551https://curecurrent.com/trials/how-to-be-safe-with-alcoholic-drinks-in-diabetes-20552https://curecurrent.com/trials/dlbs1449-in-diabetic-patients-with-low-hdl-20553https://curecurrent.com/trials/efficacy-and-safety-of-dlbs1033-in-subjects-with-type-2-diabetes-mellitus-20554https://curecurrent.com/trials/coronary-heart-disease-risk-in-type-2-diabetes-20555https://curecurrent.com/trials/nepafenac-once-daily-for-macular-edema-study-1-20556https://curecurrent.com/trials/high-protein-breakfast-on-postprandial-glycemia-in-t2d-pbd-20557https://curecurrent.com/trials/comparison-of-biodegradable-polymer-vs-durable-polymer-in-diabetic-patients-20558https://curecurrent.com/trials/study-of-metformin-and-s-baicalensis-combination-therapy-in-type-2-diabetes-mellitus-patients-20559https://curecurrent.com/trials/effects-of-co-ingesting-a-low-high-gi-meal-with-different-fat-saturation-on-postprandial-glucose-insulin-and-triacylglyc-20560https://curecurrent.com/trials/pharmacokinetic-pk-bioequivalence-and-pharmacodynamics-pd-of-julphar-insulin-30-70-and-huminsulin-profil-iii-20561https://curecurrent.com/trials/post-trial-analysis-of-a-primary-prevention-study-in-asian-indians-20562https://curecurrent.com/trials/nepafenac-once-daily-for-macular-edema-study-2-20563https://curecurrent.com/trials/cardiovascular-epidemiology-in-russian-federation-20564https://curecurrent.com/trials/surgical-intervention-for-the-treatment-of-diabetes-in-overweight-non-responders-1-20565https://curecurrent.com/trials/a-trial-investigating-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-insulin-320-in-healthy-subjects-20566https://curecurrent.com/trials/mri-derived-organ-tissue-mass-changes-with-weight-loss-ancillary-to-look-ahead-20567https://curecurrent.com/trials/heavy-metals-obesity-and-cardiovascular-risk-ancillary-to-look-ahead-20568https://curecurrent.com/trials/epidemiology-of-cardiovascular-disease-in-diabetes-20569https://curecurrent.com/trials/genetics-of-coronary-artery-disease-in-alaskan-natives-gocadan-20570https://curecurrent.com/trials/antihypertensive-and-lipid-lowering-treatment-to-prevent-heart-attack-trial-allhat-20571https://curecurrent.com/trials/strong-heart-study-20572https://curecurrent.com/trials/evaluation-of-the-translation-of-the-de-plan-program-for-the-primary-prevention-of-type-2-diabetes-in-routine-primary-ca-20573https://curecurrent.com/trials/insulin-requirement-for-pure-protein-meal-in-children-with-type-1-diabetes-on-insulin-pumps-20574https://curecurrent.com/trials/non-traditional-cardiovascular-risk-factors-in-type-2-diabetes-mellitus-ancillary-to-va-study-of-glycemic-control-20575https://curecurrent.com/trials/sleep-apnea-in-look-ahead-participants-ancillary-to-look-ahead-20576https://curecurrent.com/trials/intelligent-and-educational-system-for-gestational-diabetes-management-20577https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-ds-1971a-for-the-treatment-of-diabetic-peripheral-neuropathic-pain-dpnp-20578https://curecurrent.com/trials/complications-in-central-american-diabetic-patients-historic-cohort-20579https://curecurrent.com/trials/a-pilot-project-to-assess-the-impact-of-diabetes-education-during-ophthalmology-visits-20580https://curecurrent.com/trials/comparison-between-glp-1-analogues-and-dpp-4-inhibitors-in-type-1-diabetes-mellitus-20581https://curecurrent.com/trials/glucose-homeostasis-and-incretin-effect-t2dm-in-the-youth-a-study-of-the-malaysian-population-20582https://curecurrent.com/trials/study-of-paq-a-simple-patch-on-insulin-delivery-device-in-patients-with-type-2-diabetes-mellitus-20583https://curecurrent.com/trials/a-study-to-assess-insulin-delivery-with-paq-in-patients-with-type-2-diabetes-mellitus-20584https://curecurrent.com/trials/studies-investigating-co-morbidities-aggravating-heart-failure-20585https://curecurrent.com/trials/a-prospective-observational-study-to-assess-insulin-delivery-with-paq-in-patients-with-type-2-diabetes-mellitus-20586https://curecurrent.com/trials/demojuan-demonstration-area-for-primary-prevention-of-type-2-diabetes-juan-mina-and-barranquilla-colombia-20587https://curecurrent.com/trials/integrative-care-for-type-2-diabetes-20588https://curecurrent.com/trials/metformin-use-in-chronic-kidney-disease-the-ckd-met-study-20589https://curecurrent.com/trials/circulating-micrornas-for-discriminating-obese-preschoolers-at-risk-of-diabetes-20590https://curecurrent.com/trials/effect-of-evogliptin-on-bone-metabolism-in-human-20591https://curecurrent.com/trials/assessing-progression-to-type-2-diabetes-apt-2d-a-prospective-cohort-study-expanded-from-brite-spot-bio-bank-and-registr-20592https://curecurrent.com/trials/empowering-patients-to-better-manage-diabetes-through-self-care-20593https://curecurrent.com/trials/a-high-resolution-magnetic-resonance-imaging-study-to-evaluate-the-effect-of-rosuvastatin-on-carotid-atherosclerotic-pla-20594https://curecurrent.com/trials/safety-and-efficacy-of-topical-ar-101-compared-with-placebo-in-accelerating-granulation-tissue-formation-of-hard-to-heal-20595https://curecurrent.com/trials/effectiveness-of-sms-in-diabetes-control-20596https://curecurrent.com/trials/the-risk-of-cancer-in-users-of-regranex-becaplermin-and-matched-comparators-nonusers-of-regranex-becaplermin-20597https://curecurrent.com/trials/online-support-for-diabetes-self-management-20598https://curecurrent.com/trials/monitoring-of-nocturnal-hypoglycemia-using-earlysense-monitoring-device-20599https://curecurrent.com/trials/becaplermin-use-and-cancer-risk-in-a-patient-population-of-u-s-veterans-with-diabetes-20600https://curecurrent.com/trials/effect-of-non-surgical-treatment-of-periodontitis-on-diabetes-control-20601https://curecurrent.com/trials/structured-aerobic-and-resistance-exercise-and-gestational-diabetes-20602https://curecurrent.com/trials/patient-education-in-northtrondelag-hospital-trust-20603https://curecurrent.com/trials/this-study-aims-to-determine-the-incidence-of-hepatitis-b-diagnosis-among-diabetes-mellitus-patients-of-0-80-years-of-ag-20604https://curecurrent.com/trials/effect-of-bgg-on-glucose-metabolism-and-other-markers-of-metabolic-syndrome-20605https://curecurrent.com/trials/regenerative-cellular-therapies-physiology-pathology-and-developmental-biology-20606https://curecurrent.com/trials/efficacy-and-safety-of-mitiglinide-vs-acarbose-in-patients-with-type-2-diabetes-mellitus-20607https://curecurrent.com/trials/dexmedetomidine-for-postoperative-analgesia-after-bariatric-surgery-20608https://curecurrent.com/trials/evaluation-of-the-prandial-treatment-adjustment-effect-via-continuous-glucose-monitoring-on-type-2-diabetes-mellitus-dm-20609https://curecurrent.com/trials/20-year-changes-in-fitness-cardiovascular-disease-risk-ancillary-to-cardia-20610https://curecurrent.com/trials/low-level-laser-therapy-in-the-treatment-of-chronic-periodontitis-in-type-2-diabetics-20611https://curecurrent.com/trials/arterial-disease-multifactorial-intervention-trial-admit-20612https://curecurrent.com/trials/genetics-of-atherosclerosis-in-mexican-americans-20613https://curecurrent.com/trials/metabolic-effects-of-treatment-of-chronic-periodontitis-in-non-diabetic-subjects-20614https://curecurrent.com/trials/exploring-the-molecular-basis-to-healthy-obesity-the-diabetes-risk-assessment-study-20615https://curecurrent.com/trials/a-study-of-epoetin-beta-neorecormon-in-anemic-participants-with-diabetes-and-chronic-renal-failure-who-are-not-on-dialys-20616https://curecurrent.com/trials/interprofessional-community-based-diabetes-intervention-for-older-adults-20617https://curecurrent.com/trials/proteus-discover-in-subjects-with-uncontrolled-hypertension-and-type-2-diabetes-20618https://curecurrent.com/trials/serum-sphingolipidomic-analyses-in-healthy-diabetic-and-prediabetic-subjects-20619https://curecurrent.com/trials/ckd-396-drug-drug-interaction-study-a-ckd-396-ddi-a-p1-20620https://curecurrent.com/trials/the-endobarrier-device-a-3-year-follow-up-study-20621https://curecurrent.com/trials/the-pharmacokinetics-study-of-single-and-multiple-dose-of-sp2086-in-healthy-volunteers-20622https://curecurrent.com/trials/an-observational-study-of-patient-cohorts-who-previously-received-long-term-treatment-with-pioglitazone-or-placebo-in-ad-20623https://curecurrent.com/trials/high-protein-breakfast-on-appetite-postprandial-glycemia-and-weight-loss-in-t2d-20624https://curecurrent.com/trials/the-effect-of-saxagliptin-on-glucose-fluctuation-and-immune-regulation-in-patients-with-type-1-diabetes-20625https://curecurrent.com/trials/the-pharmacokinetics-and-pharmacodynamics-study-of-single-and-multiple-dose-of-sp2086-in-type-2-diabetes-patients-20626https://curecurrent.com/trials/the-food-effect-pharmacokinetic-material-balance-and-metabolite-identification-of-sp2086-in-healthy-volunteers-20627https://curecurrent.com/trials/maggot-debridement-therapy-versus-conventional-dressing-therapy-to-treat-diabetic-foot-ulcers-20628https://curecurrent.com/trials/the-metabolite-identification-and-material-balance-study-of-sp2086-20629https://curecurrent.com/trials/the-ddi-study-of-sp2086-and-valsartan-20630https://curecurrent.com/trials/pattern-scanning-laser-pan-retinal-photocoagulation-in-proliferative-diabetic-retinopathy-20631https://curecurrent.com/trials/the-ddi-study-of-sp2086-and-simvastatin-20632https://curecurrent.com/trials/a-trial-of-the-jejunal-diversion-procedure-20633https://curecurrent.com/trials/analysis-of-viral-infections-exposition-preceding-the-type-1-diabetes-t1d-diagnostic-in-children-of-the-isis-diab-cohort-20634https://curecurrent.com/trials/the-drug-drug-interaction-of-sp2086-and-glyburide-20635https://curecurrent.com/trials/the-drug-drug-interaction-of-sp2086-and-valsartan-20636https://curecurrent.com/trials/the-drug-drug-interaction-of-sp2086-and-simvastatin-20637https://curecurrent.com/trials/genetic-and-environmental-risk-factors-of-type-1-autoimmune-diabetes-and-its-early-complications-20638https://curecurrent.com/trials/sucralose-in-subjects-with-diabetes-mellitus-insulin-requesting-20639https://curecurrent.com/trials/web-based-education-for-diabetes-patients-on-adaptable-insulin-schedules-20640https://curecurrent.com/trials/the-drug-drug-interaction-of-sp2086-and-metformin-20641https://curecurrent.com/trials/community-health-workers-and-diabetes-education-20642https://curecurrent.com/trials/chronic-cold-acclimation-stimulates-the-browning-of-subcutaneous-white-adipose-in-patients-with-type-2-diabetes-mellitus-20643https://curecurrent.com/trials/optimization-of-interval-training-in-patients-with-type-2-diabetes-20644https://curecurrent.com/trials/efficacy-and-safety-of-eslicarbazepine-acetate-as-therapy-for-patients-with-painful-diabetic-neuropathy-20645https://curecurrent.com/trials/identification-and-metabolic-characterization-of-a-cohort-of-human-subjects-with-mutations-in-prdm-16-20646https://curecurrent.com/trials/interval-training-and-appetite-regulation-in-patients-with-type-2-diabetes-20647https://curecurrent.com/trials/defining-the-physiological-mechanisms-of-risk-genes-for-hyperglycaemia-insulin-resistance-and-type-2-diabetes-20648https://curecurrent.com/trials/the-impact-of-continuous-glucose-monitoring-use-on-sleep-in-parents-of-children-with-type-1-diabetes-mellitus-20649https://curecurrent.com/trials/efficacy-and-safety-of-dorner-tablets-and-aspirin-for-prevention-of-arteriosclerosis-progress-in-type-2-diabetes-mellitu-20650https://curecurrent.com/trials/the-role-of-arachidonic-acid-metabolites-from-patients-with-metabolic-syndrome-20651https://curecurrent.com/trials/the-correlation-between-the-retrobulbar-hemodynamics-and-intrarenal-hemodynamics-in-t2dm-patients-during-the-early-perio-20652https://curecurrent.com/trials/konjac-glucomannan-fibre-blend-and-american-ginseng-in-type-2-diabetes-20653https://curecurrent.com/trials/lifestyle-intervention-for-diabetes-and-weight-management-in-psychosis-20654https://curecurrent.com/trials/the-effect-of-dpp4-inhibitor-on-vasclular-healing-20655https://curecurrent.com/trials/metformin-for-prevention-gestational-diabetes-in-pregnant-women-with-polycystic-ovarian-syndrome-20656https://curecurrent.com/trials/a-computer-based-simulation-of-dka-management-20657https://curecurrent.com/trials/study-to-assess-the-dietary-carbohydrate-content-of-indian-diabetics-with-special-therapeutic-view-on-effectiveness-of-a-20658https://curecurrent.com/trials/predicting-hypoglycaemia-and-arrhythmias-in-the-vulnerable-patient-with-diabetes-and-chronic-kidney-disease-20659https://curecurrent.com/trials/the-correlation-between-the-pulmonary-function-and-intrarenal-hemodynamics-in-37-t2dm-patients-in-early-period-20660https://curecurrent.com/trials/metabolomic-variations-in-the-saxagliptin-treated-type-2-diabetes-mellitus-patients-20661https://curecurrent.com/trials/time-efficient-exercise-in-type-2-diabetes-20662https://curecurrent.com/trials/the-effect-of-alogliptin-on-pulmonary-function-in-obese-patients-with-type-2-diabetes-inadequately-controlled-by-metform-20663https://curecurrent.com/trials/negative-postprandial-effect-on-endothelium-after-a-not-healthy-meal-in-type-2-diabetes-as-affected-by-training-20664https://curecurrent.com/trials/acute-effects-of-dietary-fiber-on-postprandial-responses-in-lean-and-overweight-subjects-20665https://curecurrent.com/trials/measurement-of-endothelial-function-and-cardiac-output-new-methods-20666https://curecurrent.com/trials/comparison-of-the-efficacy-of-the-ultrasound-with-fluoroscopy-in-guidance-of-lumbar-sympathetic-block-20667https://curecurrent.com/trials/safety-of-overestimation-of-a-meal-insulin-bolus-in-the-context-of-dual-hormone-closed-loop-operation-20668https://curecurrent.com/trials/safety-and-tolerability-study-of-cycloset-in-treatment-of-type-2-diabetes-20669https://curecurrent.com/trials/south-asian-heart-risk-assessment-project-pilot-20670https://curecurrent.com/trials/propolis-improves-glycemic-control-in-subjects-with-type-2-diabetes-and-chronic-periodontitis-20671https://curecurrent.com/trials/patient-with-any-pathology-according-to-the-appreciation-of-the-investigator-which-could-disturb-the-participation-in-th-20672https://curecurrent.com/trials/diabetic-foot-ulcer-prevention-system-20673https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-intravenous-alpha-1-antitrypsin-in-type-1-diabetes-mellitus-20674https://curecurrent.com/trials/fecal-microbiota-transplantation-for-diabetes-mellitus-type-ii-in-obese-patients-20675https://curecurrent.com/trials/south-asian-heart-risk-assessment-project-trial-sahara-trial-20676https://curecurrent.com/trials/acute-effect-of-phototherapy-with-light-emitting-diode-led-on-muscle-and-pulmonary-oxygen-consumption-on-diabetes-mellit-20677https://curecurrent.com/trials/japanese-study-with-rimonabant-in-obese-type-2-diabetic-patients-on-diet-and-exercise-20678https://curecurrent.com/trials/safety-of-metformin-in-pregnancy-20679https://curecurrent.com/trials/effects-of-medical-and-surgical-weight-loss-on-metabolism-20680https://curecurrent.com/trials/effect-of-short-peripheral-electrical-stimulation-pes-on-blood-glucose-20681https://curecurrent.com/trials/description-of-drug-utilization-and-assessment-of-impact-of-saxagliptin-on-health-status-of-patients-with-type-2-diabete-20682https://curecurrent.com/trials/efficacy-study-of-diapep277-in-newly-diagnosed-type-1-diabetes-patients-20683https://curecurrent.com/trials/effects-of-physical-activity-coaching-on-health-and-behaviour-parameters-in-diabetic-persons-20684https://curecurrent.com/trials/japanese-study-with-rimonabant-in-obese-type-2-diabetic-patients-with-oral-anti-diabetic-drug-20685https://curecurrent.com/trials/influence-of-vitamin-d-on-vascular-function-in-adolescents-and-young-adults-with-type-1-diabetes-20686https://curecurrent.com/trials/preventing-esrd-in-overt-nephropathy-of-type-2-diabetes-20687https://curecurrent.com/trials/renal-denervation-in-diabetes-20688https://curecurrent.com/trials/renal-denervation-in-diabetic-nephropathy-20689https://curecurrent.com/trials/glucose-variability-in-type-1-diabetes-and-its-effect-on-factors-that-influence-new-vessel-formation-20690https://curecurrent.com/trials/eye-screening-in-german-secondary-diabetes-care-centers-20691https://curecurrent.com/trials/evaluation-of-the-targeted-screening-of-type-2-diabetes-by-capillary-blood-glucose-20692https://curecurrent.com/trials/medication-in-early-diabetes-med-study-20693https://curecurrent.com/trials/medico-economic-evaluation-of-enterra-therapy-20694https://curecurrent.com/trials/effect-of-liraglutide-on-clock-genes-20695https://curecurrent.com/trials/clinical-equivalency-validation-protocol-clinical-equivalency-eyenez-retina-camera-v200-and-optomed-smartscope-m5-ey3-20696https://curecurrent.com/trials/digital-glucose-monitoring-in-gestational-diabetes-20697https://curecurrent.com/trials/pilot-clinical-trial-of-ustekinumab-in-patients-with-new-onset-t1d-20698https://curecurrent.com/trials/evaluation-of-gut-absorption-rate-of-glucose-after-a-large-evening-meal-in-type-1-diabetes-20699https://curecurrent.com/trials/translational-study-for-obesity-management-in-mexican-adults-using-the-group-lifestyle-balance-program-20700https://curecurrent.com/trials/meta-analyses-of-the-effect-of-liquid-meal-replacements-on-cardiometabolic-risk-20701https://curecurrent.com/trials/evaluation-of-pharmacokinetics-safety-and-tolerability-of-ertugliflozin-pf-04971729-mk-8835-in-japanese-and-western-heal-20702https://curecurrent.com/trials/effect-of-dapagliflozin-on-quality-of-life-in-patients-with-type-2-diabetes-in-a-real-clinical-practice-20703https://curecurrent.com/trials/main-study-low-glycaemic-index-gi-diet-in-the-management-of-gdm-sub-study-the-breast-milk-sub-study-20704https://curecurrent.com/trials/trial-of-remote-evaluation-and-treatment-of-gestational-diabetes-mellitus-20705https://curecurrent.com/trials/gestational-diabetes-mellitus-and-neurodevelopment-in-newborns-20706https://curecurrent.com/trials/relationship-of-haptoglobin-phenotype-to-vascular-function-and-response-to-vitamin-e-supplementation-in-patients-with-di-20707https://curecurrent.com/trials/apelin-levels-and-g212a-polymorphism-of-apelin-receptor-apj-20708https://curecurrent.com/trials/off-target-effects-of-linagliptin-monotherapy-on-arterial-stiffness-in-early-diabetes-20709https://curecurrent.com/trials/phase-3-study-to-compare-the-efficacy-and-safety-of-gemigliptin-and-vildagliptin-as-add-on-therapy-to-metformin-in-peopl-20710https://curecurrent.com/trials/the-differential-effects-of-diabetes-therapy-on-inflammation-20711https://curecurrent.com/trials/impact-of-multidisciplinary-self-care-management-of-diabetic-nephropathy-on-quality-of-life-self-care-behavior-glycemic-20712https://curecurrent.com/trials/meta-analyses-of-the-effect-of-sucrose-versus-high-fructose-corn-syrup-on-cardiometabolic-risk-20713https://curecurrent.com/trials/renal-effects-of-dpp-4-inhibitor-linagliptin-in-type-2-diabetes-20714https://curecurrent.com/trials/meta-analyses-of-total-and-individual-fructose-containing-sugars-and-incident-cardiometabolic-disease-20715https://curecurrent.com/trials/correlation-between-the-pulmonary-function-parameters-and-the-circulatory-parameters-psv-edv-ri-of-retrobulbar-blood-ves-20716https://curecurrent.com/trials/meta-analyses-of-liquid-versus-solid-calories-and-body-weight-20717https://curecurrent.com/trials/renal-sympathetic-denervation-and-potential-effects-on-glucose-metabolism-and-cardiovascular-risk-factors-20718https://curecurrent.com/trials/glucometer-and-mobile-phone-based-data-transfer-system-in-diabetes-20719https://curecurrent.com/trials/fault-detection-zone-mpc-and-dias-system-in-t1d-20720https://curecurrent.com/trials/the-heat-study-2-year-lifestyle-intervention-in-overweight-women-to-encourage-weight-management-20721https://curecurrent.com/trials/promoting-healthy-habits-with-elderlies-diabetics-20722https://curecurrent.com/trials/epidemiology-of-impaired-coagulant-balance-in-diabetes-20723https://curecurrent.com/trials/women-s-healthy-lifestyle-project-cardiovascular-risk-factors-and-menopause-20724https://curecurrent.com/trials/epidemiology-of-idiopathic-dilated-cardiomyopathy-washington-dc-dilated-cardiomyopathy-study-20725https://curecurrent.com/trials/efficacy-of-self-hypnosis-for-weight-loss-in-type-2-diabetics-20726https://curecurrent.com/trials/insulin-androgen-and-risk-in-african-american-women-20727https://curecurrent.com/trials/prospective-study-of-diabetes-related-vascular-disease-in-oklahoma-indians-20728https://curecurrent.com/trials/postmenopausal-estrogen-progestin-interventions-pepi-20729https://curecurrent.com/trials/immunogenetic-factors-of-coronary-heart-disease-20730https://curecurrent.com/trials/mechanisms-of-pro-thrombosis-in-diabetes-mellitus-ancillary-to-bari-2d-20731https://curecurrent.com/trials/bypass-angioplasty-revascularization-investigation-bari-20732https://curecurrent.com/trials/pilot-project-community-health-assessment-program-through-emergency-medical-services-20733https://curecurrent.com/trials/framingham-cycle-v-offspring-spouse-nutrition-studies-20734https://curecurrent.com/trials/shared-decision-making-between-patients-and-gps-in-the-treatment-of-type-2-diabetes-in-primary-care-20735https://curecurrent.com/trials/the-effect-of-dairy-and-non-dairy-breakfasts-on-satiety-and-post-meal-glycemia-in-healthy-older-adults-20736https://curecurrent.com/trials/the-effect-of-dairy-and-non-dairy-alternatives-on-satiety-and-post-meal-glycemia-in-healthy-young-adults-20737https://curecurrent.com/trials/aspirin-response-in-high-risk-patients-with-coronary-artery-disease-20738https://curecurrent.com/trials/reduction-of-the-metabolic-syndrome-in-navarra-spain-20739https://curecurrent.com/trials/pre-meal-protein-drink-improve-glycemic-regulation-20740https://curecurrent.com/trials/an-act-based-application-for-young-people-with-type-1-diabetes-20741https://curecurrent.com/trials/sitagliptin-metformin-add-on-study-in-patients-with-type-2-diabetes-mellitus-20742https://curecurrent.com/trials/phase-iv-study-with-a-36-week-extension-period-to-evaluate-the-efficacy-and-safety-of-dapagliflozin-therapy-when-added-t-20743https://curecurrent.com/trials/diet-insulin-resistance-and-cardiovascular-risk-20744https://curecurrent.com/trials/modulation-of-the-intestinal-flora-with-the-probiotic-vivomixx-in-pregnant-women-at-risk-of-metabolic-complications-20745https://curecurrent.com/trials/prospective-comparison-between-sadi-s-and-gastric-bypass-20746https://curecurrent.com/trials/treatment-of-impaired-glucose-tolerance-in-pregnancy-20747https://curecurrent.com/trials/continuous-quality-improvement-for-diabetes-20748https://curecurrent.com/trials/efficacy-and-safety-of-cycloset-compared-with-placebo-when-added-to-metformin-20749https://curecurrent.com/trials/surgical-decompression-for-diabetic-neuropathy-in-the-foot-20750https://curecurrent.com/trials/et-blockade-and-exercise-induced-vascular-adaptations-in-t2dm-20751https://curecurrent.com/trials/allogeneic-umbilical-cord-mesenchymal-stem-cell-transplantation-for-type-1-diabetes-with-diabetic-ketoacidosis-20752https://curecurrent.com/trials/developing-accessible-telehealth-programs-for-diabetes-and-hypertension-management-in-bolivia-20753https://curecurrent.com/trials/effect-of-liraglutide-on-cardiovascular-endpoints-in-diabetes-mellitus-type-2-patients-20754https://curecurrent.com/trials/et-blockade-and-exercise-induced-blood-flow-in-t2dm-20755https://curecurrent.com/trials/low-glycemic-diet-intervention-and-community-diabetic-patients-20756https://curecurrent.com/trials/effect-of-rosuvastatin-on-function-of-high-density-lipoprotein-cholesterol-in-type-2-diabetes-20757https://curecurrent.com/trials/nph-and-regular-insulin-in-the-treatment-of-inpatient-hyperglycemia-comparison-of-3-basal-bolus-regimens-20758https://curecurrent.com/trials/a-trial-to-investigate-the-efficacy-pharmacokinetics-safety-and-tolerability-of-biochaperone-insulin-lispro-in-compariso-20759https://curecurrent.com/trials/respiratory-disorder-during-sleep-in-the-pregnancy-a-risk-factor-in-gestational-diabetese-20760https://curecurrent.com/trials/effect-of-lixisenatide-on-the-renal-system-20761https://curecurrent.com/trials/using-cers-to-optimize-quality-of-life-for-persons-with-diabetes-and-chronic-pain-20762https://curecurrent.com/trials/the-effect-of-motivational-short-interview-model-in-type-2-diabetic-patient-in-primary-care-in-turkey-20763https://curecurrent.com/trials/bioequivalence-study-coadministered-to-healthy-subjects-in-the-fasted-state-20764https://curecurrent.com/trials/efficacy-and-safety-ofsangrow-decoction-for-patients-with-diabetes-20765https://curecurrent.com/trials/interval-training-in-type-2-diabetics-20766https://curecurrent.com/trials/an-early-customized-low-glycaemic-index-gi-diet-prevents-lga-babies-in-overweight-obese-pregnant-women-20767https://curecurrent.com/trials/randomisation-to-endobarrier-alone-versus-with-incretin-analogue-in-sustained-diabesity-revise-diabesity-20768https://curecurrent.com/trials/weukbre5716-steroid-related-damage-in-systemic-lupus-erythematosus-hopkins-20769https://curecurrent.com/trials/glucobay-m-evaluation-of-safety-and-effectiveness-in-type-2-diabetes-not-well-controlled-on-monotherapy-in-real-life-pra-20770https://curecurrent.com/trials/prohealth-home-a-feasibility-study-investigating-the-use-of-a-lifestyle-app-in-people-at-risk-of-type-2-diabetes-20771https://curecurrent.com/trials/tolerability-to-hs-20004-with-titration-administration-in-type-2-diabetic-patients-20772https://curecurrent.com/trials/comparison-of-aqueous-and-plasma-glucose-level-in-diabetic-patients-20773https://curecurrent.com/trials/evaluation-of-blood-retinal-barrier-functional-alterations-by-optical-coherence-tomography-20774https://curecurrent.com/trials/clinical-observation-of-coronary-arterial-microcirculation-dysfunction-in-diabetic-patients-with-non-obstructive-coronar-20775https://curecurrent.com/trials/feed-back-suppression-of-meal-induced-glucagon-like-peptide-1-glp-1-secretion-20776https://curecurrent.com/trials/effects-of-dapagliflozin-on-the-incretin-sensitivity-of-the-pancreatic-beta-cell-20777https://curecurrent.com/trials/effect-of-gemigliptin-on-metabolic-endotoxemia-and-lipemia-20778https://curecurrent.com/trials/vildagliptin-metformin-in-t2dm-patients-starting-basal-insulin-20779https://curecurrent.com/trials/glycemic-durability-after-metformin-failure-20780https://curecurrent.com/trials/efficacy-and-safety-of-gemigliptin-50mg-qd-added-in-patients-with-type-2-diabetes-inadequately-controlled-on-glimepiride-20781https://curecurrent.com/trials/effects-of-vildagliptin-metformin-combination-on-markers-of-atherosclerosis-thrombosis-and-inflammation-in-diabetics-wit-20782https://curecurrent.com/trials/incretin-based-drugs-and-the-risk-of-heart-failure-20783https://curecurrent.com/trials/the-insulin-independence-trial-iit-evaluating-the-safety-and-efficacy-of-oral-cyclosporine-and-oral-lansoprazole-for-ins-20784https://curecurrent.com/trials/improving-access-to-hba1c-in-sub-saharan-africa-20785https://curecurrent.com/trials/assessment-of-an-iphone-application-on-glycemic-control-in-type-1-diabetes-20786https://curecurrent.com/trials/exercise-program-combined-or-not-with-nutritional-intervention-in-adults-with-type-2-diabetes-20787https://curecurrent.com/trials/diabetes-and-palliative-care-20788https://curecurrent.com/trials/safety-and-pharmacokinetics-study-of-a-new-drug-for-type-2-diabetes-20789https://curecurrent.com/trials/g-credit-gangnam-cohort-for-risk-evaluation-of-diabetes-and-impaired-glucose-tolerance-20790https://curecurrent.com/trials/role-of-endoplasmic-reticulum-stress-in-the-pathophysiology-of-type-2-diabetes-20791https://curecurrent.com/trials/user-evaluation-of-the-minimed-620g-and-640g-insulin-pumps-20792https://curecurrent.com/trials/future-of-beta-cells-in-adults-with-genetic-abnormality-behind-neonatal-diabetes-20793https://curecurrent.com/trials/the-insulin-independence-trial-iit-evaluating-the-safety-and-efficacy-of-oral-cyclosporine-and-oral-omeprazole-for-insul-20794https://curecurrent.com/trials/evaluation-of-accu-chek-diaport-a-port-system-for-continuous-intraperitoneal-insulin-infusion-in-patients-with-type-i-di-20795https://curecurrent.com/trials/the-early-diagnosis-of-gestational-diabetes-mellitus-study-20796https://curecurrent.com/trials/diabetes-lifestyle-assessment-and-educational-tools-20797https://curecurrent.com/trials/impact-of-nitrate-ingestion-on-protein-synthesis-20798https://curecurrent.com/trials/the-role-of-1-5-anhydro-d-glucitol-as-clinical-biomarkers-of-hypoglycemia-in-patients-with-diabetes-20799https://curecurrent.com/trials/assessment-of-intranasal-glucagon-on-endogenous-glucose-production-20800https://curecurrent.com/trials/long-term-use-of-sonias-combination-tablets-in-patients-with-type-2-diabetes-mellitus-20801https://curecurrent.com/trials/fructose-and-glucose-and-tas1r2-in-type-1-diabetes-20802https://curecurrent.com/trials/the-peripheral-mobilized-mononuclear-cell-based-therapy-in-patient-with-diabetic-neuropathy-20803https://curecurrent.com/trials/role-of-interrupting-sedentary-time-in-management-of-type-2-diabetes-20804https://curecurrent.com/trials/comparison-of-ticagrelor-and-clopidogrel-in-patients-with-coronary-artery-disease-and-type-2-diabetes-mellitus-tics-dm-20805https://curecurrent.com/trials/laparoscopic-bariatric-surgery-to-treat-type-2-diabetes-in-obese-patients-20806https://curecurrent.com/trials/the-addition-of-ipilimumab-to-carboplatin-and-etoposide-chemotherapy-for-extensive-stage-small-cell-lung-cancer-20807https://curecurrent.com/trials/vitamin-d-treatment-for-painful-diabetic-neuropathy-20808https://curecurrent.com/trials/the-performance-of-an-artificial-pancreas-at-home-in-people-with-type-1-diabetes-20809https://curecurrent.com/trials/comparative-study-of-a-smartphone-linked-self-monitoring-system-versus-a-traditional-one-for-improving-metabolic-control-20810https://curecurrent.com/trials/atherosclerosis-risk-in-communities-aric-20811https://curecurrent.com/trials/risk-factors-for-three-critical-stages-of-the-diabetic-foot-infections-20812https://curecurrent.com/trials/effectiveness-of-the-diabetes-conversation-map-program-among-diabetic-patients-in-taiwan-20813https://curecurrent.com/trials/cohort-study-of-heart-rate-variability-20814https://curecurrent.com/trials/glucose-response-excursions-and-treatment-great-study-20815https://curecurrent.com/trials/diet-for-colonoscopy-preparation-in-diabetic-patients-20816https://curecurrent.com/trials/ims-diareg-diabetes-registry-prospective-diabetes-registry-of-patients-with-type-2-diabetes-mellitus-20817https://curecurrent.com/trials/collagen-scaffolds-loaded-with-hucmscs-for-the-improvement-of-erectile-function-in-men-with-diabetes-20818https://curecurrent.com/trials/closing-the-loop-between-glucose-sensor-and-insulin-pump-developing-an-algorithm-20819https://curecurrent.com/trials/overnight-type-1-diabetes-control-under-md-logic-closed-loop-system-at-the-patient-s-home-20820https://curecurrent.com/trials/influence-of-dm-on-artery-blood-flow-and-complications-after-radial-artery-cannulation-20821https://curecurrent.com/trials/d-chiro-inositol-in-overweight-type-1-diabetes-patients-20822https://curecurrent.com/trials/evolution-of-effectiveness-of-diabetes-medical-care-in-russia-20823https://curecurrent.com/trials/immune-response-of-patients-with-chronic-staphylococcus-aureus-infected-wounds-20824https://curecurrent.com/trials/newborns-of-obese-mothers-20825https://curecurrent.com/trials/perindopril-vs-ramipril-for-persistence-in-mau-reduction-study-20826https://curecurrent.com/trials/sciatic-nerve-blocks-with-or-without-femoral-block-versus-spinal-anaesthesia-in-patients-undergoing-diabetic-foot-surger-20827https://curecurrent.com/trials/meta-analysis-in-post-marketing-surveillances-for-sglt2-inhibitors-in-patients-with-type-2-diabetes-mellitus-20828https://curecurrent.com/trials/sitagliptin-and-kinetics-of-triglyceride-rich-lipoproteins-apolipoprotein-b48-and-b100-in-patients-with-type-2-diabetes-20829https://curecurrent.com/trials/intraocular-anti-vegf-compared-with-intraocular-triamcinolone-in-patients-with-diabetic-macular-edema-20830https://curecurrent.com/trials/incretin-axis-in-type-1-diabetes-mellitus-20831https://curecurrent.com/trials/impact-of-a-built-in-insulin-calculator-feature-on-diabetes-control-pilot-study-20832https://curecurrent.com/trials/effect-of-biphasic-insulin-aspart-30-combined-with-metformin-on-blood-glucose-control-in-subjects-with-type-2-diabetes-i-20833https://curecurrent.com/trials/efficacy-and-safety-comparative-study-of-sitagliptin-vildagliptin-and-saxagliptin-20834https://curecurrent.com/trials/exit-prospective-study-of-the-response-to-exercise-20835https://curecurrent.com/trials/glp-1-effects-on-insulin-and-glucagon-in-ptdm-20836https://curecurrent.com/trials/shockwave-therapy-of-chronic-diabetic-foot-ulcers-20837https://curecurrent.com/trials/the-effects-of-bindarit-in-diabetic-nephropathy-20838https://curecurrent.com/trials/treatment-of-overweight-and-obese-children-using-the-holbaek-method-in-a-municipality-based-treatment-program-20839https://curecurrent.com/trials/vasopressin-and-v2-receptor-in-meniere-s-disease-20840https://curecurrent.com/trials/study-of-two-titration-algorithms-with-insulin-glargine-300-units-ml-in-type-2-diabetes-mellitus-patients-20841https://curecurrent.com/trials/a-multiple-ascending-dose-phase-i-study-of-dbpr108-in-healthy-male-subjects-20842https://curecurrent.com/trials/an-observational-cross-sectional-study-to-assess-the-prevalence-of-chronic-kidney-disease-ckd-in-type-2-diabetes-patient-20843https://curecurrent.com/trials/effect-of-sglt-2-inhibitor-dapagliflozin-on-glycemic-variability-in-patients-with-diabetes-mellitus-type-2-20844https://curecurrent.com/trials/effect-of-gastrectomy-and-anastomosis-on-diabetes-and-hypertension-in-early-gastric-cancer-patients-20845https://curecurrent.com/trials/influence-of-liraglutide-a-glp-1-receptor-agonist-on-brown-adipose-tissue-bat-activity-in-humans-20846https://curecurrent.com/trials/a-radiolabeled-mass-balance-study-of-14c-ertugliflozin-pf04971729-mk-8835-in-healthy-male-participants-mk-8835-038-20847https://curecurrent.com/trials/a-phase-iiib-study-to-evaluate-the-safety-and-efficacy-of-gemigliptin-in-type-2-diabetes-mellitus-patients-with-moderate-20848https://curecurrent.com/trials/dose-response-and-variability-of-inhaled-insulin-in-type-2-diabetes-20849https://curecurrent.com/trials/liraglutide-efficacy-and-action-in-non-alcoholic-steatohepatitis-20850https://curecurrent.com/trials/relationship-between-level-of-hemoglobin-a1c-and-platelet-function-in-patients-undergoing-cardiac-surgery-20851https://curecurrent.com/trials/pharmacologic-response-and-safety-of-inhaled-insulin-in-type-1-diabetes-20852https://curecurrent.com/trials/national-heart-lung-and-blood-institute-twin-study-20853https://curecurrent.com/trials/efficacy-study-of-the-diamond-system-to-treat-type-2-diabetes-mellitus-20854https://curecurrent.com/trials/glycemic-index-and-insulinemic-index-of-3-types-of-tortilla-in-mexican-adults-20855https://curecurrent.com/trials/cardiovascular-disease-mortality-in-the-nas-nrc-twin-registry-20856https://curecurrent.com/trials/axillary-block-properties-in-diabetic-patients-20857https://curecurrent.com/trials/the-diamond-for-the-treatment-of-type-2-diabetes-20858https://curecurrent.com/trials/health-coaching-to-effect-lifestyle-behaviour-change-20859https://curecurrent.com/trials/intraarterial-infusion-of-autologous-bone-marrow-in-diabetic-patients-with-chronic-ischemia-of-lower-limbs-cli-no-revasc-20860https://curecurrent.com/trials/va-hdl-intervention-trial-va-hit-ancillary-study-data-analysis-20861https://curecurrent.com/trials/to-investigate-the-efficacy-and-safety-of-individualized-doses-of-biochaperone-insulin-lispro-in-comparison-to-humalog-u-20862https://curecurrent.com/trials/impact-of-n-3-polyunsaturated-fatty-acids-in-a-protein-enriched-diet-with-low-gi-in-type-2-diabetes-patients-20863https://curecurrent.com/trials/consequences-and-correlates-of-weight-fluctuations-20864https://curecurrent.com/trials/sit-less-2-effect-of-sitting-less-on-glucose-regulation-in-people-with-diabetes-mellitus-type-2-20865https://curecurrent.com/trials/comparison-of-the-change-in-fat-distribution-in-overweight-and-obese-subjects-with-type-2-diabetes-after-insulin-treatme-20866https://curecurrent.com/trials/a-phase-1-study-in-japanese-subjects-with-type-2-diabetes-mellitus-as-monotherapy-20867https://curecurrent.com/trials/anti-diabetic-effects-of-persimmon-leaf-extract-20868https://curecurrent.com/trials/incretin-based-drugs-and-pancreatic-cancer-20869https://curecurrent.com/trials/high-potency-statins-and-the-risk-of-diabetes-20870https://curecurrent.com/trials/variation-of-glucose-values-at-early-stages-of-diabetes-continuous-glucose-monitoring-20871https://curecurrent.com/trials/botulinum-toxin-in-peripheral-neuropathic-pain-20872https://curecurrent.com/trials/mobile-sipoo-telemonitoring-with-combined-with-active-assistance-technology-20873https://curecurrent.com/trials/encourage-evaluating-community-peer-advisors-and-diabetes-outcomes-in-rural-alabama-20874https://curecurrent.com/trials/the-use-of-home-oral-glucose-tolerance-test-kit-in-screening-cystic-fibrosis-related-diabetes-20875https://curecurrent.com/trials/ala-on-glycemic-control-in-t2dm-participants-20876https://curecurrent.com/trials/effects-of-resveratrol-on-inflammation-in-type-2-diabetic-patients-20877https://curecurrent.com/trials/incidence-of-diabetes-and-cardiovascular-disease-in-mexican-americans-20878https://curecurrent.com/trials/study-of-the-mechanisms-of-metabolic-adaptations-to-overfeeding-20879https://curecurrent.com/trials/diabetes-and-cardiovascular-risk-in-mexico-city-san-antonio-heart-study-20880https://curecurrent.com/trials/endothelial-function-in-patients-with-type-2-diabetes-versus-healthy-subjects-20881https://curecurrent.com/trials/a-study-of-dulaglutide-in-chinese-participants-20882https://curecurrent.com/trials/post-marketing-surveillance-study-of-biphasic-insulin-aspart-30-20883https://curecurrent.com/trials/evaluation-of-fenugreek-seed-extract-in-type-2-diabetes-an-add-on-study-20884https://curecurrent.com/trials/prandial-orientated-biphasic-insulin-aspart-30-therapy-the-physiological-premix-insulin-therapy-for-type-2-diabetes-20885https://curecurrent.com/trials/paediatric-subjects-special-survey-20886https://curecurrent.com/trials/observational-study-to-evaluate-the-safety-of-novomix-30-flexpen-20887https://curecurrent.com/trials/special-survey-for-patients-with-type-1-or-type-2-diabetes-20888https://curecurrent.com/trials/can-hba1c-replace-ogtt-for-the-diagnosis-of-diabetes-mellitus-among-chinese-patients-with-ifg-20889https://curecurrent.com/trials/sensor-and-software-use-for-improved-glucose-control-in-mdi-managed-diabetes-20890https://curecurrent.com/trials/self-control-trial-to-evaluate-the-remission-rate-in-newly-diagnosed-type-2-diabetes-patients-after-treatment-with-insul-20891https://curecurrent.com/trials/special-survey-for-type-1-or-type-2-diabetic-patients-20892https://curecurrent.com/trials/special-survey-for-paediatric-subjects-20893https://curecurrent.com/trials/special-survey-of-production-of-insulin-aspart-specific-antibody-20894https://curecurrent.com/trials/protective-effect-on-the-coronary-microcirculation-of-patients-with-diabetes-by-clopidogrel-or-ticagrelor-20895https://curecurrent.com/trials/minimed-640g-system-user-evaluation-with-the-question-of-reducing-the-rate-of-hypoglycemia-20896https://curecurrent.com/trials/comparison-of-basal-fasting-glycemic-control-in-type-1-diabetic-patients-with-csii-achieved-by-the-circadian-slide-ruler-20897https://curecurrent.com/trials/a-monocenter-open-label-glucose-clamp-study-examining-the-metabolic-effect-of-insulin-infusion-intervals-for-basal-insul-20898https://curecurrent.com/trials/clinical-study-opened-of-cutaneous-acceptability-of-a-topic-product-in-normal-conditions-of-use-20899https://curecurrent.com/trials/observational-study-in-type-2-diabetes-treated-by-an-intensive-insulin-treatment-ict-containing-once-daily-levemir-insul-20900https://curecurrent.com/trials/observational-study-of-patients-with-diabetes-using-levemir-flexpen-20901https://curecurrent.com/trials/observational-study-of-the-switch-of-metformin-alone-to-metformin-combined-with-repaglinide-in-type-2-diabetes-20902https://curecurrent.com/trials/the-impact-of-initiating-switching-to-insulin-detemir-on-emotional-well-being-and-treatment-satisfaction-20903https://curecurrent.com/trials/safety-of-insulin-detemir-for-the-treatment-of-insulin-dependent-type-1-or-type-2-diabetes-mellitus-20904https://curecurrent.com/trials/prisma-study-prospective-randomized-trial-on-intensive-self-monitoring-blood-glucose-management-added-value-in-non-insul-20905https://curecurrent.com/trials/evaluation-of-the-use-of-levemir-in-insufficiently-controlled-patients-with-type-1-or-type-2-diabetes-20906https://curecurrent.com/trials/a-study-comparing-continuous-subcutaneous-insulin-infusion-with-multiple-daily-injections-with-insulin-lispro-and-glargi-20907https://curecurrent.com/trials/efficacy-and-safety-of-repaglinide-and-metformin-combination-therapy-in-type-2-diabetes-failing-on-oral-anti-diabetic-dr-20908https://curecurrent.com/trials/comparison-of-the-management-of-post-prandial-hyperglycemia-by-multiple-bolus-calculators-20909https://curecurrent.com/trials/vitamin-d-supplements-on-markers-for-cardiovascular-disease-and-diabetes-an-individual-participant-data-meta-analysis-20910https://curecurrent.com/trials/vildagliptin-vs-sitagliptin-add-on-to-insulin-impact-on-glycemic-profile-and-correlation-of-hypoglycemic-episodes-and-he-20911https://curecurrent.com/trials/alpha-lipoic-acid-for-treatment-of-diabetic-neuropathy-20912https://curecurrent.com/trials/optimizing-the-beneficial-health-effects-of-exercise-for-diabetes-focus-on-the-liver-20913https://curecurrent.com/trials/dairy-lipids-proteins-and-the-metabolic-syndrome-dairyhealth-20914https://curecurrent.com/trials/study-of-efficacy-and-safety-of-vildagliptin-as-add-on-insulin-therapy-in-t2dm-patients-20915https://curecurrent.com/trials/the-effect-of-different-food-products-on-post-prandial-blood-glucose-in-pregnant-woman-with-diabetes-20916https://curecurrent.com/trials/cirrhosis-effects-of-transplantation-and-diabetes-20917https://curecurrent.com/trials/human-faecal-microbiota-in-type-2-diabetes-20918https://curecurrent.com/trials/safety-and-efficacy-of-low-intensity-shockwave-therapy-in-treating-diabetic-foot-ulcers-20919https://curecurrent.com/trials/the-effect-of-pioglitazone-on-neointima-volume-and-inflammatory-markers-20920https://curecurrent.com/trials/diabetes-specific-nutritional-formulas-versus-oatmeal-20921https://curecurrent.com/trials/human-factors-and-home-use-study-of-the-vigilant-diabetes-management-application-20922https://curecurrent.com/trials/relation-of-visceral-fat-and-associated-cytokines-with-early-cardiovascular-complications-in-type-1-diabetes-20923https://curecurrent.com/trials/metabolic-signalling-in-muscle-and-adipose-tissue-following-insulin-withdrawal-and-growth-hormone-injection-20924https://curecurrent.com/trials/effects-of-linagliptin-in-addition-to-empagliflozin-on-islet-cell-physiology-20925https://curecurrent.com/trials/a-study-of-phyllanthus-niruri-and-sida-cordifolia-in-diabetic-peripheral-polyneuropathy-20926https://curecurrent.com/trials/11c-5-htp-pet-in-clinical-islet-transplantation-20927https://curecurrent.com/trials/diabetes-coaching-study-20928https://curecurrent.com/trials/open-non-comparative-multi-centre-post-marketing-clinical-follow-up-investigation-to-evaluate-performance-and-safety-on-20929https://curecurrent.com/trials/feel4diabetes-study-20930https://curecurrent.com/trials/arginase-inhibition-and-microvascular-endothelial-function-in-type-2-diabetes-20931https://curecurrent.com/trials/diabetes-in-india-nutrition-guidelines-study-dings-20932https://curecurrent.com/trials/observational-study-of-type-1-and-type-2-diabetes-patients-having-switched-from-human-premixes-to-novomix-30-20933https://curecurrent.com/trials/csii-in-type-1-diabetes-diet-quality-of-life-cardiometabolic-risks-a-cross-sectional-study-20934https://curecurrent.com/trials/paclitaxel-eluting-balloon-versus-drug-eluting-stent-in-native-coronary-artery-stenoses-of-diabetic-patients-20935https://curecurrent.com/trials/phase-1-study-to-explore-the-safety-and-pharmacokinetics-of-dapaglifozin-in-adolescents-and-adults-with-type-1-diabetes-20936https://curecurrent.com/trials/csii-in-type-1-diabetes-diet-quality-of-life-cardiometabolic-risks-a-longitudinal-study-20937https://curecurrent.com/trials/effects-of-chronic-dietary-exposure-to-branched-chain-amino-acids-20938https://curecurrent.com/trials/visceral-adiposity-and-cvd-risk-in-women-20939https://curecurrent.com/trials/hyperapo-b-and-coronary-heart-disease-20940https://curecurrent.com/trials/serum-total-homocysteine-and-c-reactive-protein-ancillary-to-idnt-20941https://curecurrent.com/trials/long-term-predictors-of-morbidity-in-older-age-20942https://curecurrent.com/trials/prenatal-nutrition-and-adult-disease-20943https://curecurrent.com/trials/cardiac-and-renal-disease-study-cards-20944https://curecurrent.com/trials/epidemiology-of-cardiovascular-and-non-cardiovascular-risk-in-chicago-20945https://curecurrent.com/trials/adiposity-and-fat-patterning-in-black-americans-20946https://curecurrent.com/trials/evaluation-of-novel-risk-factors-and-clinical-outcomes-of-acute-myocardial-infarction-20947https://curecurrent.com/trials/predisposition-genes-in-monogenic-diabetes-diamono-20948https://curecurrent.com/trials/effects-of-sitaglpitin-on-endothelial-function-during-the-ogtt-in-t2dm-20949https://curecurrent.com/trials/digestive-tract-reconstruction-after-gastrectomy-of-gastric-cancer-with-type-2-diabetes-20950https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk8245-8245-004-completed-20951https://curecurrent.com/trials/effect-of-topic-pirfenidone-in-diabetic-ulcers-20952https://curecurrent.com/trials/the-effect-of-prostaglandin-i2-on-the-endothelial-cell-function-disorder-in-type-2-diabetes-mellitus-patients-20953https://curecurrent.com/trials/intranasal-insulin-and-its-effect-on-postprandial-metabolism-in-comparison-to-subcutaneous-insulin-20954https://curecurrent.com/trials/assessment-of-the-neurovascular-microcirculatory-response-in-diabetes-type-1-patients-20955https://curecurrent.com/trials/efficacy-of-sasi-bypass-for-type-2-diabetic-obese-patients-20956https://curecurrent.com/trials/prevalence-of-unknown-and-known-diabetes-in-patients-with-frozen-shoulder-20957https://curecurrent.com/trials/genetics-of-the-metabolic-syndrome-in-japanese-americans-20958https://curecurrent.com/trials/endobarrier-sans-in-over-weight-or-obese-type-2-diabetic-subjects-20959https://curecurrent.com/trials/central-obesity-and-disease-risk-in-japanese-americans-20960https://curecurrent.com/trials/multiple-dose-trial-of-anti-glycation-agent-gly-230-in-healthy-and-diabetic-subjects-20961https://curecurrent.com/trials/nutritional-therapy-and-education-with-multimedia-application-in-patients-with-type-2-diabetes-20962https://curecurrent.com/trials/comparison-of-insulin-detemir-produced-by-the-current-process-and-the-nn729-process-in-healthy-subjects-20963https://curecurrent.com/trials/enhancing-support-for-women-at-risk-for-heart-disease-20964https://curecurrent.com/trials/lifestyle-management-for-women-with-chd-and-niddm-20965https://curecurrent.com/trials/investigate-the-effect-of-food-on-the-pharmacokinetic-characteristics-of-ckd-395-in-healthy-male-volunteers-20966https://curecurrent.com/trials/wisconsin-epidemiological-study-of-cardiovascular-disease-in-type-1-diabetes-20967https://curecurrent.com/trials/bypass-angioplasty-revascularization-investigation-in-type-2-diabetes-20968https://curecurrent.com/trials/multi-ethnic-study-of-atherosclerosis-mesa-ancillary-eye-study-20969https://curecurrent.com/trials/a-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk-5823-in-overweight-or-obese-participants-20970https://curecurrent.com/trials/a-study-to-test-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-mk1006-mk-1006-002-completed-20971https://curecurrent.com/trials/januvia-re-examination-study-mk-0431-181-20972https://curecurrent.com/trials/physician-led-counseling-in-management-of-depression-in-type-2-diabetes-mellitus-20973https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-mk8245-in-patients-with-type-2-diabetes-mellitus-and-inadequate-glycemic-co-20974https://curecurrent.com/trials/a-study-of-sitagliptin-in-patients-with-type-2-diabetes-mellitus-who-have-inadequate-glycemic-control-on-diet-exercise-t-20975https://curecurrent.com/trials/pioglitazone-add-on-study-in-patients-with-type-2-diabetes-mellitus-20976https://curecurrent.com/trials/a-multiple-dose-study-of-mk-1006-mk-1006-004-terminated-20977https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-of-two-formulations-of-mk-1006-mk-1006-010-am1-completed-20978https://curecurrent.com/trials/nutritional-intervention-of-type-ii-diabetes-mellitus-by-vitamin-d-in-qatar-20979https://curecurrent.com/trials/the-reduced-insulinotropic-effect-of-a-continuous-infusion-relative-to-a-bolus-injection-of-gip-20980https://curecurrent.com/trials/single-doses-of-mk-0941-in-type-2-diabetics-mk-0941-027-20981https://curecurrent.com/trials/comparative-study-of-insulin-therapy-between-inner-and-outer-upper-thigh-20982https://curecurrent.com/trials/integrated-diabetes-management-protocol-using-smartphone-20983https://curecurrent.com/trials/safety-and-exploratory-efficacy-study-of-collagen-membrane-with-mesenchymal-stem-cells-in-the-treatment-of-skin-defects-20984https://curecurrent.com/trials/atorvastatin-versus-vitamin-e-in-treatment-of-non-alcoholic-fatty-liver-disease-20985https://curecurrent.com/trials/liquid-protein-preloads-with-different-carbohydrate-types-effects-on-the-glycaemic-and-insulinaemic-response-20986https://curecurrent.com/trials/studying-the-effect-of-capsinoids-on-brown-fat-using-infrared-thermal-imaging-20987https://curecurrent.com/trials/incretin-based-therapy-for-poorly-controlled-type-2-diabetic-patients-20988https://curecurrent.com/trials/a-24-week-multicenter-prospective-open-labeled-single-arm-exploratory-phase-4-clinical-trial-to-evaluate-the-safety-and-20989https://curecurrent.com/trials/the-efficacy-and-safety-study-in-patients-with-type-2-diabetes-mellitus-20990https://curecurrent.com/trials/study-to-determine-ethnic-differences-in-the-glycaemic-response-to-nutritional-formula-drinks-20991https://curecurrent.com/trials/comparison-between-losartan-and-benazepril-in-diabetic-hypertensive-patients-not-controlled-by-amlodipine-20992https://curecurrent.com/trials/risk-factors-for-atherogenesis-in-type-1-diabetes-20993https://curecurrent.com/trials/fgf-21-and-exercise-in-relation-to-insulin-secretion-20994https://curecurrent.com/trials/effects-of-rosiglitazone-on-inflammatory-markers-and-adipokines-in-diabetic-patients-using-an-angiotensin-receptor-block-20995https://curecurrent.com/trials/system-accuracy-evaluation-of-karajishi-contour-and-karajishi-ts-blood-glucose-monitoring-systems-following-iso-15197-20-20996https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-musashino-diabetes-diet-in-type-ii-diabetes-mellitus-disease-20997https://curecurrent.com/trials/efficacy-safety-study-of-glimepiride-to-type-2-diabetes-patients-based-on-metformin-and-basal-insulin-treatment-20998https://curecurrent.com/trials/evaluation-of-novel-trend-arrow-adjustment-tool-for-diabetes-patients-using-continuous-glucose-monitoring-to-guide-insul-20999https://curecurrent.com/trials/effects-of-ginger-supplementation-on-nf-kb-in-peripheral-blood-mononuclear-cells-in-type-2-diabetes-mellitus-21000